1
|
Lin Y, Li H, Wu H, Li S, Abakumov MA, Chekhonin VP, Peltzer K, Abbas KS, Makatsariya AD, Liu Z, Zhang J, Xue Y, Zhang C. Age-related Disparities in Pan-Cancer Mortality and Causes of Death: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. J Cancer 2024; 15:1613-1623. [PMID: 38370383 PMCID: PMC10869975 DOI: 10.7150/jca.91758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Accepted: 01/07/2024] [Indexed: 02/20/2024] Open
Abstract
Comprehensive analysis of mortality and causes of death (COD) in cancers was of importance to conduct intervention strategies. The current study aimed to investigate the mortality rate and COD among cancers, and to explore the disparities between age. Initially, cancer patients diagnosed between 2010 and 2019 from the surveillance, epidemiology, and end results (SEER) database were extracted. Then, frequencies and percentage of deaths, and mortality rate in different age groups were calculated. Meanwhile, age distribution of different COD across tumor types was illustrated while the standardized mortality ratios (SMR) stratified by age were calculated and visualized. A total of 2,670,403 death records were included and digestive system cancer (688,953 death cases) was the most common primary cancer type. The mortality rate increased by 5.6% annually in total death, 4.0% in cancer-specific death and 10.9% in non-cancer cause. As for cancer-specific death, the age distribution varied among different primary tumor types due to prone age and prognosis of cancer. The top five non-cancer causes in patients older than 50 were cardiovascular and cerebrovascular disease, other causes, COPD and associated conditions, diabetes as well as Alzheimer. The SMRs of these causes were higher among younger patients and gradually dropped in older age groups. Mortality and COD of cancer patients were heterogeneous in age group due to primary tumor types, prone age and prognosis of cancer. Our study conducted that non-cancer COD was a critical part in clinical practice as well as cancer-specific death. Individualized treatment and clinical intervention should be made after fully considering of the risk factor for death in different diagnosis ages and tumor types.
Collapse
Affiliation(s)
- Yile Lin
- Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
| | - Huiyang Li
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China; Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China
| | - Haixiao Wu
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Shu Li
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Public Service Management, School of Management, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Maxim A Abakumov
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- National University of Science and Technology (MISIS), Moscow, Russia
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow, Russia
| | - Vladimir P Chekhonin
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow, Russia
| | - Karl Peltzer
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Research & Innovation, University of Limpopo, Sovenga, Limpopo, South Africa
| | - Kirellos Said Abbas
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Faculty of Medicine, Alexandria University, Alexandria, Egypt
| | - Alexander D Makatsariya
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Obstetrics, Gynecology and Perinatal Medicine, Filatov Clinical Institute of Children's Health, Sechenov University, Moscow, Russia
| | - Zheng Liu
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Department of Orthopaedic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
| | - Jin Zhang
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
| | - Yuan Xue
- Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, China
| | - Chao Zhang
- The Sino-Russian Joint Research Center for Bone Metastasis in Malignant Tumor, Tianjin, China
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow, Russia
| |
Collapse
|
2
|
Sokol MB, Beganovskaya VA, Mollaeva MR, Yabbarov NG, Chirkina MV, Belykh DV, Startseva OM, Egorov AE, Kostyukov AA, Kuzmin VA, Lomakin SM, Shilkina NG, Krivandin AV, Shatalova OV, Gradova MA, Abakumov MA, Nikitin AA, Maksimova VP, Kirsanov KI, Nikolskaya ED. Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative. Pharmaceutics 2024; 16:126. [PMID: 38258135 PMCID: PMC10818748 DOI: 10.3390/pharmaceutics16010126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 01/08/2024] [Accepted: 01/15/2024] [Indexed: 01/24/2024] Open
Abstract
In this study, we described physico-chemical properties of novel nanoformulation of photosensitizer-pyropheophorbide α 17-diethylene glycol ester (XL) (chlorophyll α derivative), revealing insights into antitumor activity and maintaining quality, meeting the pharmaceutical approach of new nanoformulation design. Our formulation, based on poly(lactic-co-glycolic acid) (PLGA) nanoparticles, increased XL solubility and selective tumor-targeted accumulation. In our research, we revealed, for the first time, that XL binding to polyvinyl alcohol (PVA) enhances XL photophysical activity, providing the rationale for PVA application as a stabilizer for nanoformulations. Results of FTIR, DSC, and XRD revealed the physical interactions between XL and excipients, including PVA, indicating that the encapsulation maintained XL binding to PVA. The encapsulated XL exhibited higher photophysical activity compared to non-encapsulated substance, which can be attributed to the influence of residual PVA. Gamma-irradiation led to degradation of XL; however, successful sterilization of the samples was achieved through the filtration. Importantly, the encapsulated and sterilized XL retained cytotoxicity against both 2D and 3D tumor cell models, demonstrating the potential of the formulated NP-XL for photodynamic therapy applications, but lacked the ability to reactivate epigenetically silenced genes. These findings provide valuable insights into the design and characterization of PLGA-based nanoparticles for the encapsulation of photosensitizers.
Collapse
Affiliation(s)
- Maria B. Sokol
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Veronika A. Beganovskaya
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Mariia R. Mollaeva
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Nikita G. Yabbarov
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Margarita V. Chirkina
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Dmitry V. Belykh
- Institute of Chemistry, Komi Scientific Center, Ural Division of the Russian Academy of Sciences, 167982 Syktyvkar, Russia;
| | - Olga M. Startseva
- Pitirim Sorokin Syktyvkar State University, 167001 Syktyvkar, Russia;
| | - Anton E. Egorov
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Alexey A. Kostyukov
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Vladimir A. Kuzmin
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
- National Research Nuclear University MEPhI, 115409 Moscow, Russia
| | - Sergei M. Lomakin
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
- N. N. Semenov Federal Research Center for Chemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia; (N.G.S.)
| | - Natalia G. Shilkina
- N. N. Semenov Federal Research Center for Chemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia; (N.G.S.)
| | - Alexey V. Krivandin
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Olga V. Shatalova
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| | - Margarita A. Gradova
- N. N. Semenov Federal Research Center for Chemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia; (N.G.S.)
| | - Maxim A. Abakumov
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), 119049 Moscow, Russia; (M.A.A.); (A.A.N.)
| | - Aleksey A. Nikitin
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), 119049 Moscow, Russia; (M.A.A.); (A.A.N.)
| | - Varvara P. Maksimova
- Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia; (V.P.M.); (K.I.K.)
| | - Kirill I. Kirsanov
- Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia; (V.P.M.); (K.I.K.)
| | - Elena D. Nikolskaya
- N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334 Moscow, Russia; (M.B.S.); (V.A.B.); (M.R.M.); (M.V.C.); (A.E.E.); (V.A.K.); (S.M.L.); (A.V.K.); (O.V.S.)
| |
Collapse
|
3
|
Garanina AS, Vishnevskiy DA, Chernysheva AA, Valikhov MP, Malinovskaya JA, Lazareva PA, Semkina AS, Abakumov MA, Naumenko VA. Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors. Pharmaceuticals (Basel) 2023; 16:1564. [PMID: 38004431 PMCID: PMC10674452 DOI: 10.3390/ph16111564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 10/27/2023] [Accepted: 11/03/2023] [Indexed: 11/26/2023] Open
Abstract
Insufficient drug accumulation in tumors is still a major concern for using cancer nanotherapeutics. Here, the neutrophil-based delivery of three nanoparticle types-liposomes, PLGA, and magnetite nanoparticles-was assessed both in vitro and in vivo. Confocal microscopy and a flow cytometry analysis demonstrated that all the studied nanoparticles interacted with neutrophils from the peripheral blood of mice with 4T1 mammary adenocarcinoma without a significant impact on neutrophil viability or activation state. Intravital microscopy of the tumor microenvironment showed that the neutrophils did not engulf the liposomes after intravenous administration, but facilitated nanoparticle extravasation in tumors through micro- and macroleakages. PLGA accumulated along the vessel walls in the form of local clusters. Later, PLGA nanoparticle-loaded neutrophils were found to cross the vascular barrier and migrate towards the tumor core. The magnetite nanoparticles extravasated in tumors both via spontaneous macroleakages and on neutrophils. Overall, the specific type of nanoparticles largely determined their behavior in blood vessels and their neutrophil-mediated delivery to the tumor. Since neutrophils are the first to migrate to the site of inflammation, they can increase nanodrug delivery effectiveness for nanomedicine application.
Collapse
Affiliation(s)
- Anastasiia S. Garanina
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology «MISIS», 119049 Moscow, Russia;
| | - Daniil A. Vishnevskiy
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (D.A.V.); (M.P.V.); (P.A.L.); (A.S.S.)
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (A.A.C.); (V.A.N.)
| | - Anastasia A. Chernysheva
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (A.A.C.); (V.A.N.)
| | - Marat P. Valikhov
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (D.A.V.); (M.P.V.); (P.A.L.); (A.S.S.)
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (A.A.C.); (V.A.N.)
| | | | - Polina A. Lazareva
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (D.A.V.); (M.P.V.); (P.A.L.); (A.S.S.)
| | - Alevtina S. Semkina
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (D.A.V.); (M.P.V.); (P.A.L.); (A.S.S.)
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (A.A.C.); (V.A.N.)
| | - Maxim A. Abakumov
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology «MISIS», 119049 Moscow, Russia;
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (D.A.V.); (M.P.V.); (P.A.L.); (A.S.S.)
| | - Victor A. Naumenko
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (A.A.C.); (V.A.N.)
| |
Collapse
|
4
|
Nikitin AA, Prishchepa AV, Rytov RA, Chekhonin VP, Abakumov MA. Unveiling the Role of the Properties of Magnetic Nanoparticles for Highly Efficient Low-Frequency Magneto-Mechanical Actuation of Biomolecules. J Phys Chem Lett 2023; 14:9112-9117. [PMID: 37792541 DOI: 10.1021/acs.jpclett.3c01944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/06/2023]
Abstract
The role of the properties of magnetic nanoparticles in the remote magneto-mechanical actuation of biomolecules under the influence of external magnetic fields is still of particular interest. Here, a specially designed strategy based on the mechanical destruction of short oligonucleotide duplexes is used to demonstrate the effect of magnetic nanoparticles with different sizes (5-99 nm) on the magnitude of the magneto-mechanical actuations in a low-frequency alternating magnetic field. The results show that the mechanical destruction of complementary chains of duplexes, caused by the rotational-vibrational movements of nanoparticles upon exposure to a magnetic field, has a nonmonotonic dependence on the nanoparticle core size. The main hypothesis of this phenomenon is associated with a key role of magneto-dipole interactions between individual nanoparticles, which blocks the movements of nanoparticles in dense clusters. This result will allow fine-tuning of the magnetic nanoparticle properties for addressing specific magneto-mechanical tasks.
Collapse
Affiliation(s)
- Aleksey A Nikitin
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow 119049, Russia
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Anastasiia V Prishchepa
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow 119049, Russia
| | - Ruslan A Rytov
- Pushkov Institute of Terrestrial Magnetism, Ionosphere and Radio Wave Propagation, Russian Academy of Sciences, IZMIRAN, 142190 Troitsk, Moscow, Russia
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Maxim A Abakumov
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow 119049, Russia
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow 117997, Russia
| |
Collapse
|
5
|
Zhang C, Morozova AY, Abakumov MA, Mel'nikov PA, Gabashvili AN, Chekhonin VP. Evaluation of the Optimal Number of Implanted Mesenchymal Stem Cells for the Treatment of Post-Traumatic Syrinx and Recovery of Motor Activity after Chronic Spinal Cord Injury. Bull Exp Biol Med 2023; 175:557-568. [PMID: 37773573 DOI: 10.1007/s10517-023-05904-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Indexed: 10/01/2023]
Abstract
The present work aims at determining the most effective dose (number) of mesenchymal stem cells (MSC) for its transplantation in order to treat chronic spinal cord injury (SCI) in mature Sprague-Dawley rats (n=24). MSC were obtained from bone marrow of 4-6-month-old Sprague-Dawley rats. Four weeks after SCI, MSC suspension (4 μl) was injected to experimental animals into the injured area in doses of 4×105, 8×105, or 106. Using MRI, diffusion tensor imaging (DTI), diffusion tensor tractography (DTT), immunohistochemistry, histological staining, and behavioral tests, we studied the effect of transplantation of MSC in different doses on the following parameters in rats with SCI: the size of lesion cavity and post-traumatic syrinx (PTS), glial scar formation, neuronal fibers remodeling, axonal regeneration and sprouting, vascularization, expression of neuronal factors, and motor functions. MSC administration improved motor function in rats after SCI due to stimulation of regeneration and sprouting of the axons, enhanced recovery of locomotor functions, reduction of PTS and the glial scar, and stimulation of vascularization and expression of the neurotrophic factors. The effects of MSC were dose-dependent; the most effective dose was 106 cells.
Collapse
Affiliation(s)
- C Zhang
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
- Department of Basic and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.
| | - A Yu Morozova
- Department of Basic and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M A Abakumov
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - P A Mel'nikov
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A N Gabashvili
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Chekhonin
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
- Department of Basic and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
6
|
Efimova AS, Ustimova MA, Chmelyuk NS, Abakumov MA, Fedorov YV, Fedorova OA. Specific Fluorescent Probes for Imaging DNA in Cell-Free Solution and in Mitochondria in Living Cells. Biosensors (Basel) 2023; 13:734. [PMID: 37504132 PMCID: PMC10377282 DOI: 10.3390/bios13070734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 07/03/2023] [Accepted: 07/12/2023] [Indexed: 07/29/2023]
Abstract
New styryl dyes consisting of N-methylpyridine or N-methylquinoline scaffolds were synthesized, and their binding affinities for DNA in cell-free solution were studied. The replacement of heterocyclic residue from the pyridine to quinoline group as well as variation in the phenyl part strongly influenced their binding modes, binding affinities, and spectroscopic responses. Biological experiments showed the low toxicity of the obtained dyes and their applicability as selective dyes for mitochondria in living cells.
Collapse
Affiliation(s)
- Anna S Efimova
- Laboratory of Photoactive Supramolecular Systems, A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova Str. 28, 119334 Moscow, Russia
- Department of Technology of Fine Organic Synthesis and Chemistry of Dyes, Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya Sqr. 9, 125047 Moscow, Russia
| | - Mariya A Ustimova
- Laboratory of Photoactive Supramolecular Systems, A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova Str. 28, 119334 Moscow, Russia
| | - Nelly S Chmelyuk
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova Str. 1, 117997 Moscow, Russia
| | - Maxim A Abakumov
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova Str. 1, 117997 Moscow, Russia
| | - Yury V Fedorov
- Laboratory of Photoactive Supramolecular Systems, A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova Str. 28, 119334 Moscow, Russia
| | - Olga A Fedorova
- Laboratory of Photoactive Supramolecular Systems, A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova Str. 28, 119334 Moscow, Russia
- Department of Technology of Fine Organic Synthesis and Chemistry of Dyes, Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya Sqr. 9, 125047 Moscow, Russia
| |
Collapse
|
7
|
Nizamov TR, Amirov AA, Kuznetsova TO, Dorofievich IV, Bordyuzhin IG, Zhukov DG, Ivanova AV, Gabashvili AN, Tabachkova NY, Tepanov AA, Shchetinin IV, Abakumov MA, Savchenko AG, Majouga AG. Synthesis and Functional Characterization of Co xFe 3-xO 4-BaTiO 3 Magnetoelectric Nanocomposites for Biomedical Applications. Nanomaterials (Basel) 2023; 13:811. [PMID: 36903693 PMCID: PMC10004808 DOI: 10.3390/nano13050811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Revised: 02/13/2023] [Accepted: 02/15/2023] [Indexed: 06/18/2023]
Abstract
Nowadays, magnetoelectric nanomaterials are on their way to finding wide applications in biomedicine for various cancer and neurological disease treatment, which is mainly restricted by their relatively high toxicity and complex synthesis. This study for the first time reports novel magnetoelectric nanocomposites of CoxFe3-xO4-BaTiO3 series with tuned magnetic phase structures, which were synthesized via a two-step chemical approach in polyol media. The magnetic CoxFe3-xO4 phases with x = 0.0, 0.5, and 1.0 were obtained by thermal decomposition in triethylene glycol media. The magnetoelectric nanocomposites were synthesized by the decomposition of barium titanate precursors in the presence of a magnetic phase under solvothermal conditions and subsequent annealing at 700 °C. X-ray diffraction revealed the presence of both spinel and perovskite phases after annealing with average crystallite sizes in the range of 9.0-14.5 nm. Transmission electron microscopy data showed two-phase composite nanostructures consisting of ferrites and barium titanate. The presence of interfacial connections between magnetic and ferroelectric phases was confirmed by high-resolution transmission electron microscopy. Magnetization data showed expected ferrimagnetic behavior and σs decrease after the nanocomposite formation. Magnetoelectric coefficient measurements after the annealing showed non-linear change with a maximum of 89 mV/cm*Oe with x = 0.5, 74 mV/cm*Oe with x = 0, and a minimum of 50 mV/cm*Oe with x = 0.0 core composition, that corresponds with the coercive force of the nanocomposites: 240 Oe, 89 Oe and 36 Oe, respectively. The obtained nanocomposites show low toxicity in the whole studied concentration range of 25-400 μg/mL on CT-26 cancer cells. The synthesized nanocomposites show low cytotoxicity and high magnetoelectric effects, therefore they can find wide applications in biomedicine.
Collapse
Affiliation(s)
- Timur R. Nizamov
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Abdulkarim A. Amirov
- Amirkhanov Institute of Physics of Dagestan Federal Research Center, Russian Academy of Sciences, 367003 Makhachkala, Russia
| | - Tatiana O. Kuznetsova
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Irina V. Dorofievich
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Igor G. Bordyuzhin
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Dmitry G. Zhukov
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Anna V. Ivanova
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Anna N. Gabashvili
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Nataliya Yu. Tabachkova
- Department of Materials Science of Semiconductors and Dielectrics, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | | | - Igor V. Shchetinin
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Maxim A. Abakumov
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
- Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia
| | - Alexander G. Savchenko
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
| | - Alexander G. Majouga
- Department of Physical Materials Science, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
- Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia
- Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia
| |
Collapse
|
8
|
Chmelyuk NS, Oda VV, Gabashvili AN, Abakumov MA. Encapsulins: Structure, Properties, and Biotechnological Applications. Biochemistry Moscow 2023; 88:35-49. [PMID: 37068871 PMCID: PMC9937530 DOI: 10.1134/s0006297923010042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
In 1994 a new class of prokaryotic compartments was discovered, collectively called "encapsulins" or "nanocompartments". Encapsulin shell protomer proteins self-assemble to form icosahedral structures of various diameters (24-42 nm). Inside of nanocompartments shells, one or several cargo proteins, diverse in their functions, can be encapsulated. In addition, non-native cargo proteins can be loaded into nanocompartments, and shell surfaces can be modified via various compounds, which makes it possible to create targeted drug delivery systems, labels for optical and MRI imaging, and to use encapsulins as bioreactors. This review describes a number of strategies of encapsulins application in various fields of science, including biomedicine and nanobiotechnologies.
Collapse
Affiliation(s)
- Nelly S Chmelyuk
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
- Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, 117977, Russia
| | - Vera V Oda
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
| | - Anna N Gabashvili
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
| | - Maxim A Abakumov
- National University of Science and Technology "MISIS", Moscow, 119049, Russia.
- Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, 117977, Russia
| |
Collapse
|
9
|
Nikolenko PI, Nizamov TR, Bordyuzhin IG, Abakumov MA, Baranova YA, Kovalev AD, Shchetinin IV. Structure and Magnetic Properties of SrFe 12-xIn xO 19 Compounds for Magnetic Hyperthermia Applications. Materials (Basel) 2022; 16:ma16010347. [PMID: 36614686 PMCID: PMC9821793 DOI: 10.3390/ma16010347] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 12/26/2022] [Accepted: 12/27/2022] [Indexed: 05/14/2023]
Abstract
In this work, complex studies of the structure and magnetic properties of SrFe12-xInxO19 powders obtained by the mechanochemical and citrate methods were carried out. The solubility of In in strontium hexaferrite SrFe₁₂O₁₉ at 1200 °C was determined. The structure and properties of the powders were studied using X-ray diffraction analysis, Mössbauer spectroscopy and scanning electron microscopy. Measurements of magnetic properties in magnetic fields up to 1600 kA/m were also performed. Additionally, the hyperthermia effect was investigated. The possibility of controlling the coercivity of the samples in the range from 188.9 kA/m to 22.3 kA/m and saturation magnetization from 63.5 A·m2/kg to 44.2 A·m2/kg with an increase in the degree of In doping was also demonstrated. Investigation of the magnetic hyperthermia of the samples was carried out by temperature measurement with an IR camera when they were introduced into alternating magnetic fields of various frequencies (144, 261 and 508 kHz) and amplitudes (between 11.96 and 19.94 kA/m). According to the study result, there was detected the heating of the SrFe12-xInxO19 sample (x = 1.7). The highest values of magnetic hyperthermia of the sample were observed in a 19.94 kA/m magnetic field and a frequency of 261 kHz. At a concentration of 56.67 g/L, the sample was heated from 23 to 41 °C within 2 min. The parameters SLP (specific loss power) and ILP (intrinsic loss power) were calculated.
Collapse
|
10
|
Gabashvili AN, Chmelyuk NS, Sarkisova VA, Melnikov PA, Semkina AS, Nikitin AA, Abakumov MA. Myxococcus xanthus Encapsulin as a Promising Platform for Intracellular Protein Delivery. Int J Mol Sci 2022; 23:ijms232415591. [PMID: 36555233 PMCID: PMC9778880 DOI: 10.3390/ijms232415591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/05/2022] [Accepted: 12/06/2022] [Indexed: 12/13/2022] Open
Abstract
Introducing a new genetically encoded material containing a photoactivatable label as a model cargo protein, based on Myxococcus xanthus (Mx) encapsulin system stably expressed in human 293T cells. Encapsulin from Mx is known to be a protein-based container for a ferritin-like cargo in its shell which could be replaced with an exogenous cargo protein, resulting in a modified encapsulin system. We replaced Mx natural cargo with a foreign photoactivatable mCherry (PAmCherry) fluorescent protein and isolated encapsulins, containing PAmCherry, from 293T cells. Isolated Mx encapsulin shells containing photoactivatable label can be internalized by macrophages, wherein the PAmCherry fluorescent signal remains clearly visible. We believe that a genetically encoded nanocarrier system obtained in this study, can be used as a platform for controllable delivery of protein/peptide therapeutics in vitro.
Collapse
Affiliation(s)
- Anna N. Gabashvili
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Avenue, 4, 119049 Moscow, Russia
| | - Nelly S. Chmelyuk
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Avenue, 4, 119049 Moscow, Russia
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova Street, 1, 117997 Moscow, Russia
| | - Viktoria A. Sarkisova
- Biology Faculty, Lomonosov Moscow State University, Leninskiy Gory, 119234 Moscow, Russia
- Cell Proliferation Laboratory, Engelhardt Institute of Molecular Biology, Vavilova Street, 32, 119991 Moscow, Russia
| | - Pavel A. Melnikov
- Department of Basic and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Kropotkinskiy Lane, 23, 119991 Moscow, Russia
| | - Alevtina S. Semkina
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova Street, 1, 117997 Moscow, Russia
- Department of Basic and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Kropotkinskiy Lane, 23, 119991 Moscow, Russia
| | - Aleksey A. Nikitin
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Avenue, 4, 119049 Moscow, Russia
| | - Maxim A. Abakumov
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Avenue, 4, 119049 Moscow, Russia
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova Street, 1, 117997 Moscow, Russia
- Correspondence:
| |
Collapse
|
11
|
Karshieva SS, Glinskaya EG, Dalina AA, Akhlyustina EV, Makarova EA, Khesuani YD, Chmelyuk NS, Abakumov MA, Khochenkov DA, Mironov VA, Meerovich GA, Kogan EA, Koudan EV. Antitumor activity of photodynamic therapy with tetracationic derivative of synthetic bacteriochlorin in spheroid culture of liver and colon cancer cells. Photodiagnosis Photodyn Ther 2022; 40:103202. [PMID: 36400167 DOI: 10.1016/j.pdpdt.2022.103202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 10/27/2022] [Accepted: 11/14/2022] [Indexed: 11/17/2022]
Abstract
Efficient screening of photosensitizers (PS) as well as studying their photodynamic activity, especially PS excited in the near-infrared region, require informative in vitro models to adequately reflect the architecture, thickness, and intercellular interactions in tumors. In our study, we used spheroids formed from human colon cancer HCT-116 cells and liver cancer Huh7 cells to assess the phototoxicity of a new PS based on tetracationic derivative of synthetic bacteriochlorin (BC4). We optimized conditions for the irradiation regime based on the kinetics of BC4 accumulation in spheroids and kinetics of spheroid growth. Although PS accumulated more efficiently in HCT-116 cells, characterized by more aggressive growth and high proliferative potential, they were less susceptible to the photodynamic therapy (PDT) compared to the slower growing Huh7 cells. We also showed that 3D models of spheroids were less sensitive to BC4 than conventional 2D cultures with relatively identical kinetics of drug accumulation. Our findings suggest that BC4 is a perspective agent for photodynamic therapy against cancer cells.
Collapse
Affiliation(s)
- Saida Sh Karshieva
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; N N Blokhin National Medical Research Center of Oncology, Kashirskoe shosse 24, Moscow 115478, Russia
| | - Elizaveta G Glinskaya
- I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia
| | - Alexandra A Dalina
- The Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Vavilov st. 32, Moscow 119991, Russia
| | | | - Elena A Makarova
- Organic Intermediates and Dyes Institute, B. Sadovaya st. 1/4, Moscow 123001, Russia
| | - Yusef D Khesuani
- Laboratory for Biotechnological Research "3D Bioprinting Solutions", Kashirskoe shosse 68, Moscow 115409, Russia
| | - Nelly S Chmelyuk
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova st. 1, Moscow 117997, Russia
| | - Maxim A Abakumov
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova st. 1, Moscow 117997, Russia
| | - Dmitriy A Khochenkov
- N N Blokhin National Medical Research Center of Oncology, Kashirskoe shosse 24, Moscow 115478, Russia; Togliatti State University, Belorusskaya st. 14, Togliatti 445667, Russia
| | - Vladimir A Mironov
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia; National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia
| | - Gennady A Meerovich
- National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia; Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Vavilov st. 38, Moscow 119991, Russia
| | - Evgeniya A Kogan
- I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia
| | - Elizaveta V Koudan
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia.
| |
Collapse
|
12
|
Ustimova MA, Fedorov YV, Chmelyuk NS, Abakumov MA, Fedorova OA. Fluorescence turn-on probes for intracellular DNA/RNA distribution based on asymmetric bis(styryl) dyes. Spectrochim Acta A Mol Biomol Spectrosc 2022; 279:121446. [PMID: 35667137 DOI: 10.1016/j.saa.2022.121446] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 05/24/2022] [Accepted: 05/26/2022] [Indexed: 06/15/2023]
Abstract
Two bis(styryl) dyes, varying in type of spacer between two mono(styryl) units, were tested for interactions with ct-DNA or cl-RNA. Both compounds showed strong affinity toward ds-DNA/ss-RNA, the binding mode of the interaction is shifting between DNA groove binding to RNA intercalation. Consequently, interaction with DNA shows a stronger flare-up of fluorescence (151 times for dye 1 and 118 times for dye 2) than when binding with RNA (23 times and 36 times correspondingly). The presence of energy transfer in the bis(styryl) system increases the Stokes shift of the dye, so when irradiating the system in the region of 370-380 nm, fluorescence is detected at 610-620 nm. The biological experiments showed that the efficient intracellular fluorescence quench was observed in the DNase digest test suggested that dyes can be applied by recognition of DNA in the presence of RNA molecules.
Collapse
Affiliation(s)
- Maria A Ustimova
- Laboratory of Photoactive Supramolecular Systems, A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, 119991 Moscow, Russia.
| | - Yuri V Fedorov
- Laboratory of Photoactive Supramolecular Systems, A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, 119991 Moscow, Russia
| | - Nelly S Chmelyuk
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova str. 1, 117997 Moscow, Russia
| | - Maxim A Abakumov
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova str. 1, 117997 Moscow, Russia
| | - Olga A Fedorova
- Laboratory of Photoactive Supramolecular Systems, A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, 119991 Moscow, Russia.
| |
Collapse
|
13
|
Naumenko VA, Vishnevskiy DA, Stepanenko AA, Sosnovtseva AO, Chernysheva AA, Abakumova TO, Valikhov MP, Lipatova AV, Abakumov MA, Chekhonin VP. In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells. Biomedicines 2022; 10:biomedicines10071697. [PMID: 35885002 PMCID: PMC9313019 DOI: 10.3390/biomedicines10071697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 07/01/2022] [Accepted: 07/10/2022] [Indexed: 11/28/2022] Open
Abstract
Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, however, the complex interplay between Ad and liver cells is not fully understood. Here, by using intravital microscopy, we aimed to follow the infection and immune response in mouse liver from the first minutes up to 72 h post intravenous injection of three Ads carrying delta-24 modification (Ad5-RGD, Ad5/3, and Ad5/35). At 15–30 min following the infusion of Ad5-RGD and Ad5/3 (but not Ad5/35), the virus-bound macrophages demonstrated signs of zeiosis: the formation of long-extended protrusions and dynamic membrane blebbing with the virus release into the blood in the membrane-associated vesicles. Although real-time imaging revealed interactions between the neutrophils and virus-bound KCs within minutes after treatment, and long-term contacts of CD8+ T cells with transduced hepatocytes at 24–72 h, depletion of neutrophils and CD8+ T cells affected neither rate nor dynamics of liver infection. Ad5-RGD failed to complete replicative cycle in hepatocytes, and transduced cells remained impermeable for propidium iodide, with a small fraction undergoing spontaneous apoptosis. In Ad5-RGD-immune mice, the virus neither killed KCs nor transduced hepatocytes, while in the setting of hepatic regeneration, Ad5-RGD enhanced liver transduction. The clinical and biochemical signs of hepatotoxicity correlated well with KC death, but not hepatocyte transduction. Real-time in vivo tracking for dynamic interactions between virus and host cells provides a better understanding of mechanisms underlying Ad-related hepatotoxicity.
Collapse
Affiliation(s)
- Victor A. Naumenko
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
- Correspondence:
| | - Daniil A. Vishnevskiy
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
| | - Aleksei A. Stepanenko
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
| | - Anastasiia O. Sosnovtseva
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
| | - Anastasiia A. Chernysheva
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
| | - Tatiana O. Abakumova
- Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30, 121205 Moscow, Russia;
| | - Marat P. Valikhov
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
| | - Anastasiia V. Lipatova
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia;
| | - Maxim A. Abakumov
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), 119049 Moscow, Russia
| | - Vladimir P. Chekhonin
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia; (D.A.V.); (A.A.S.); (A.O.S.); (A.A.C.); (M.P.V.); (V.P.C.)
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
| |
Collapse
|
14
|
Spector DV, Pavlov KG, Akasov RA, Vaneev AN, Erofeev AS, Gorelkin PV, Nikitina VN, Lopatukhina EV, Semkina AS, Vlasova KY, Skvortsov DA, Roznyatovsky VA, Ul'yanovskiy NV, Pikovskoi II, Sypalov SA, Garanina AS, Vodopyanov SS, Abakumov MA, Volodina YL, Markova AA, Petrova AS, Mazur DM, Sakharov DA, Zyk NV, Beloglazkina EK, Majouga AG, Krasnovskaya OO. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position. J Med Chem 2022; 65:8227-8244. [PMID: 35675651 DOI: 10.1021/acs.jmedchem.1c02136] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
We report herein the design, synthesis, and biological investigation of a series of novel Pt(IV) prodrugs with non-steroidal anti-inflammatory drugs naproxen, diclofenac, and flurbiprofen, as well as these with stearic acid in the axial position. Six Pt(IV) prodrugs 5-10 were designed, which showed superior antiproliferative activity compared to cisplatin as well as an ability to overcome tumor cell line resistance to cisplatin. By tuning the drug lipophilicity via variation of the axial ligands, the most potent Pt(IV) prodrug 7 was obtained, with an enhanced cellular accumulation of up to 153-fold that of cisplatin and nanomolar cytotoxicity both in 2D and 3D cell cultures. Pt2+ species were detected at different depths of MCF-7 spheroids after incubation with Pt(IV) prodrugs using a Pt-coated carbon nanoelectrode. Cisplatin accumulation in vivo in the murine mammary EMT6 tumor tissue of BALB/c mice after Pt(IV) prodrug injection was proved electrochemically as well. The drug tolerance study on BALB/c mice showed good tolerance of 7 in doses up to 8 mg/kg.
Collapse
Affiliation(s)
- Daniil V Spector
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Kirill G Pavlov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Roman A Akasov
- I.M. Sechenov First Moscow State Medical University, Trubetskaya 8-2, Moscow 119991, Russia.,Federal Scientific Research Center "Crystallography and Photonics" Russian Academy of Sciences, Leninskiy Prospect 59, Moscow 119333, Russia
| | - Alexander N Vaneev
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Alexander S Erofeev
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Petr V Gorelkin
- National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Vita N Nikitina
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Elena V Lopatukhina
- National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Alevtina S Semkina
- Pirogov Russian National Research Medical University (RNRMU), Ostrovitianov 1, Moscow 117997, Russia.,Department of Basic and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Kropotkinskiy 23, Moscow 119034, Russia
| | - Kseniya Yu Vlasova
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,Pirogov Russian National Research Medical University (RNRMU), Ostrovitianov 1, Moscow 117997, Russia
| | - Dmitrii A Skvortsov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Vitaly A Roznyatovsky
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Nikolay V Ul'yanovskiy
- Core Facility Center "Arktika", Northern (Arctic) Federal University, Arkhangelsk 163002, Russia
| | - Ilya I Pikovskoi
- Core Facility Center "Arktika", Northern (Arctic) Federal University, Arkhangelsk 163002, Russia
| | - Sergey A Sypalov
- Core Facility Center "Arktika", Northern (Arctic) Federal University, Arkhangelsk 163002, Russia
| | - Anastasiia S Garanina
- National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Stepan S Vodopyanov
- National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| | - Maxim A Abakumov
- National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia.,Pirogov Russian National Research Medical University (RNRMU), Ostrovitianov 1, Moscow 117997, Russia
| | - Yulia L Volodina
- N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Kashirskoe highway 23, Moscow 115478, Russia
| | - Alina A Markova
- Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences, Kosygin Street, 4, Moscow 119334, Russia.,A.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences (INEOS RAS), Vavilova 28, Moscow 119991, Russia
| | - Albina S Petrova
- Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya str. 6, Moscow 117198, Russia.,State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Marshal Novikov str. 23, Moscow 123098, Russia
| | - Dmitrii M Mazur
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Dmitry A Sakharov
- Mendeleev University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russia
| | - Nikolay V Zyk
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Elena K Beloglazkina
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia
| | - Alexander G Majouga
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia.,Mendeleev University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russia
| | - Olga O Krasnovskaya
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.,National University of Science and Technology (MISIS), Leninskiy prospect 4, Moscow 119049, Russia
| |
Collapse
|
15
|
Gusliakova OI, Prikhozhdenko ES, Plastun VO, Mayorova OA, Shushunova NA, Abdurashitov AS, Kulikov OA, Abakumov MA, Gorin DA, Sukhorukov GB, Sindeeva OA. Renal Artery Catheterization for Microcapsules' Targeted Delivery to the Mouse Kidney. Pharmaceutics 2022; 14:1056. [PMID: 35631642 PMCID: PMC9144148 DOI: 10.3390/pharmaceutics14051056] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2022] [Revised: 05/07/2022] [Accepted: 05/12/2022] [Indexed: 02/04/2023] Open
Abstract
The problem of reducing the side effects associated with drug distribution throughout the body in the treatment of various kidney diseases can be solved by effective targeted drug delivery. The method described herein involves injection of a drug encapsulated in polyelectrolyte capsules to achieve prolonged local release and long-term capillary retention of several hours while these capsules are administered via the renal artery. The proposed method does not imply disruption (puncture) of the renal artery or aorta and is suitable for long-term chronic experiments on mice. In this study, we compared how capsule size and dosage affect the target kidney blood flow. It has been established that an increase in the diameter of microcapsules by 29% (from 3.1 to 4.0 μm) requires a decrease in their concentration by at least 50% with the same suspension volume. The photoacoustic method, along with laser speckle contrast imaging, was shown to be useful for monitoring blood flow and selecting a safe dose. Capsules contribute to a longer retention of a macromolecular substance in the target kidney compared to its free form due to mechanical retention in capillaries and slow impregnation into surrounding tissues during the first 1-3 h, which was shown by fluorescence tomography and microscopy. At the same time, the ability of capillaries to perform almost complete "self-cleaning" from capsular shells during the first 12 h leads to the preservation of organ tissues in a normal state. The proposed strategy, which combines endovascular surgery and the injection of polymer microcapsules containing the active substance, can be successfully used to treat a wide range of nephropathies.
Collapse
Affiliation(s)
- Olga I. Gusliakova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
| | - Ekaterina S. Prikhozhdenko
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
| | - Valentina O. Plastun
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
| | - Oksana A. Mayorova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
| | - Natalia A. Shushunova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
| | - Arkady S. Abdurashitov
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 3 Nobel Str., 143005 Moscow, Russia; (A.S.A.); (G.B.S.)
| | - Oleg A. Kulikov
- Institute of Medicine, National Research Ogarev Mordovia State University, 68 Bolshevistskaya Str., 430005 Saransk, Russia;
| | - Maxim A. Abakumov
- Department of Medical Nanobiotecnology, Pirogov Russian National Research Medical University, 1 Ostrovityanova Str., 117997 Moscow, Russia;
| | - Dmitry A. Gorin
- Center for Photonics and Quantum Materials, Skolkovo Institute of Science and Technology, 3 Nobel Str., 143005 Moscow, Russia;
| | - Gleb B. Sukhorukov
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 3 Nobel Str., 143005 Moscow, Russia; (A.S.A.); (G.B.S.)
- School of Engineering and Materials Science, Queen Mary University of London, Mile End Road, London E1 4NS, UK
| | - Olga A. Sindeeva
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia; (E.S.P.); (V.O.P.); (O.A.M.); (N.A.S.)
- Center for Neurobiology and Brain Restoration, Skolkovo Institute of Science and Technology, 3 Nobel Str., 143005 Moscow, Russia; (A.S.A.); (G.B.S.)
| |
Collapse
|
16
|
Gabashvili AN, Efremova MV, Vodopyanov SS, Chmelyuk NS, Oda VV, Sarkisova VA, Leonova MK, Semkina AS, Ivanova AV, Abakumov MA. New Approach to Non-Invasive Tumor Model Monitoring via Self-Assemble Iron Containing Protein Nanocompartments. Nanomaterials (Basel) 2022; 12:1657. [PMID: 35630878 PMCID: PMC9145190 DOI: 10.3390/nano12101657] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 04/29/2022] [Accepted: 05/09/2022] [Indexed: 02/04/2023]
Abstract
According to the World Health Organization, breast cancer is the most common oncological disease worldwide. There are multiple animal models for different types of breast carcinoma, allowing the research of tumor growth, metastasis, and angiogenesis. When studying these processes, it is crucial to visualize cancer cells for a prolonged time via a non-invasive method, for example, magnetic resonance imaging (MRI). In this study, we establish a new genetically encoded material based on Quasibacillus thermotolerans (Q.thermotolerans, Qt) encapsulin, stably expressed in mouse 4T1 breast carcinoma cells. The label consists of a protein shell containing an enzyme called ferroxidase. When adding Fe2+, a ferroxidase oxidizes Fe2+ to Fe3+, followed by iron oxide nanoparticles formation. Additionally, genes encoding mZip14 metal transporter, enhancing the iron transport, were inserted into the cells via lentiviral transduction. The expression of transgenic sequences does not affect cell viability, and the presence of magnetic nanoparticles formed inside encapsulins results in an increase in T2 relaxivity.
Collapse
Affiliation(s)
- Anna N. Gabashvili
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
- Transplantation Immunology Laboratory, Biomedical Technology Department, National Medical Research Center for Hematology, Novy Zykovsky Drive, 4A, 125167 Moscow, Russia
| | - Maria V. Efremova
- Department of Chemistry and TUM School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany;
- Institute for Synthetic Biomedicine, Helmholtz Zentrum München GmbH, Ingolstaedter Landstr. 1, 85764 Neuherberg, Germany
- Department of Applied Physics, Eindhoven University of Technology, Cascade P.O. Box 513, 5600 MB Eindhoven, The Netherlands
| | - Stepan S. Vodopyanov
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
- Biology Faculty, Lomonosov Moscow State University, Leninskiy Gory, 119234 Moscow, Russia;
| | - Nelly S. Chmelyuk
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova St., 1, 117997 Moscow, Russia;
| | - Vera V. Oda
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
| | - Viktoria A. Sarkisova
- Biology Faculty, Lomonosov Moscow State University, Leninskiy Gory, 119234 Moscow, Russia;
- Cell Proliferation Laboratory, Engelhardt Institute of Molecular Biology, Vavilova Street, 32, 119991 Moscow, Russia
| | - Maria K. Leonova
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
| | - Alevtina S. Semkina
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova St., 1, 117997 Moscow, Russia;
- Department of Basic and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Kropotkinskiy Per. 23, 119991 Moscow, Russia
| | - Anna V. Ivanova
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
| | - Maxim A. Abakumov
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (S.S.V.); (N.S.C.); (V.V.O.); (M.K.L.); (A.V.I.)
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova St., 1, 117997 Moscow, Russia;
| |
Collapse
|
17
|
Garanina AS, Nikitin AA, Abakumova TO, Semkina AS, Prelovskaya AO, Naumenko VA, Erofeev AS, Gorelkin PV, Majouga AG, Abakumov MA, Wiedwald U. Cobalt Ferrite Nanoparticles for Tumor Therapy: Effective Heating versus Possible Toxicity. Nanomaterials (Basel) 2021; 12:38. [PMID: 35009988 PMCID: PMC8746458 DOI: 10.3390/nano12010038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Revised: 12/15/2021] [Accepted: 12/20/2021] [Indexed: 05/16/2023]
Abstract
Magnetic nanoparticles (MNPs) are widely considered for cancer treatment, in particular for magnetic hyperthermia (MHT). Thereby, MNPs are still being optimized for lowest possible toxicity on organisms while the magnetic properties are matched for best heating capabilities. In this study, the biocompatibility of 12 nm cobalt ferrite MNPs, functionalized with citrate ions, in different dosages on mice and rats of both sexes was investigated for 30 days after intraperitoneal injection. The animals' weight, behavior, and blood cells changes, as well as blood biochemical parameters are correlated to histological examination of organs revealing that cobalt ferrite MNPs do not have toxic effects at concentrations close to those used previously for efficient MHT. Moreover, these MNPs demonstrated high specific loss power (SLP) of about 400 W g-1. Importantly the MNPs retained their magnetic properties inside tumor tissue after intratumoral administration for several MHT cycles within three days. Thus, cobalt ferrite MNPs represent a perspective platform for tumor therapy by MHT due to their ability to provide effective heating without exerting a toxic effect on the organism. This opens up new avenues for smaller MNPs sizes while their heating efficiency is maintained.
Collapse
Affiliation(s)
- Anastasiia S. Garanina
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
| | - Alexey A. Nikitin
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
| | | | - Alevtina S. Semkina
- Department of Medical Nanobiotechnology, Russian National Research Medical University, 117997 Moscow, Russia;
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia;
| | - Alexandra O. Prelovskaya
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
| | - Victor A. Naumenko
- V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia;
| | - Alexander S. Erofeev
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
- Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Peter V. Gorelkin
- Medical Nanotechnology LLC, Skolkovo Innovation Center, 121205 Moscow, Russia;
| | - Alexander G. Majouga
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
- Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia
- D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia
| | - Maxim A. Abakumov
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
- Department of Medical Nanobiotechnology, Russian National Research Medical University, 117997 Moscow, Russia;
| | - Ulf Wiedwald
- National University of Science and Technology «MISiS», 119049 Moscow, Russia; (A.S.G.); (A.A.N.); (A.O.P.); (A.S.E.); (A.G.M.); (M.A.A.)
- Center for Nanointegration Duisburg-Essen, Faculty of Physics, University of Duisburg-Essen, 47057 Duisburg, Germany
| |
Collapse
|
18
|
Popov AL, Abakumov MA, Savintseva IV, Ermakov AM, Popova NR, Ivanova OS, Kolmanovich DD, Baranchikov AE, Ivanov VK. Biocompatible dextran-coated gadolinium-doped cerium oxide nanoparticles as MRI contrast agents with high T 1 relaxivity and selective cytotoxicity to cancer cells. J Mater Chem B 2021; 9:6586-6599. [PMID: 34369536 DOI: 10.1039/d1tb01147b] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Gd-based complexes are widely used as magnetic resonance imaging (MRI) contrast agents. The safety of previously approved contrast agents is questionable and is being re-assessed. The main causes of concern are possible gadolinium deposition in the brain and the development of systemic nephrogenic fibrosis after repeated use of MRI contrasts. Thus, there is an urgent need to develop a new generation of MRI contrasts that are safe and that have high selectivity in tissue accumulation with improved local contrast. Here, we report on a new type of theranostic MRI contrast, namely dextran stabilised, gadolinium doped cerium dioxide nanoparticles. These ultra-small (4-6 nm) Ce0.9Gd0.1O1.95 nanoparticles have been shown to possess excellent colloidal stability and high r1-relaxivity (3.6 mM-1 s-1). They are effectively internalised by human normal and cancer cells and demonstrate dose-dependent selective cytotoxicity to cancer cells.
Collapse
Affiliation(s)
- A L Popov
- Kurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences, Leninsky av., 31, Moscow 119991, Russia.
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Nikitin AA, Yurenya AY, Gabbasov RR, Cherepanov VM, Polikarpov MA, Chuev MA, Majouga AG, Panchenko VY, Abakumov MA. Effects of Macromolecular Crowding on Nanoparticle Diffusion: New Insights from Mössbauer Spectroscopy. J Phys Chem Lett 2021; 12:6804-6811. [PMID: 34270251 DOI: 10.1021/acs.jpclett.1c01984] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
In this work, we used Mössbauer spectroscopy as a new approach for experimental quantification of the self-diffusion coefficient (DMössbauer) and hydrodynamic (HD) size of iron-containing nanoparticles (NPs) in complex crowded solutions, mimicking cell cytoplasm. As a probe, we used 9 nm cobalt ferrite NPs (CFNs) dispersed in solutions of bovine serum albumin (BSA) with a volume fraction (φBSA) of 0-0.2. Our results show that the broadening of Mössbauer spectra is highly sensitive to the diffusion of CFNs, while when φBSA = 0.2, the CFN-normalized diffusivity is reduced by 86% compared to that of a protein-free solution. CFN colloids were also studied by dynamic light scattering (DLS). Comparison of the experimental data shows that DLS significantly underestimates the diffusion coefficient of CFNs and, consequently, overestimates the HD size of CFNs at φBSA > 0, which cannot be attributed to the formation of the BSA monolayer on the surface of CFNs.
Collapse
Affiliation(s)
- Aleksey A Nikitin
- National University of Science and Technology MISiS, Moscow 119049, Russian Federation
| | - Anton Yu Yurenya
- Lomonosov Moscow State University, Moscow 119991, Russian Federation
- National Research Centre "Kurchatov Institute", Moscow 123182, Russian Federation
| | - Raul R Gabbasov
- National Research Centre "Kurchatov Institute", Moscow 123182, Russian Federation
| | - Valeriy M Cherepanov
- National Research Centre "Kurchatov Institute", Moscow 123182, Russian Federation
| | - Mikhail A Polikarpov
- National Research Centre "Kurchatov Institute", Moscow 123182, Russian Federation
| | - Michael A Chuev
- Valiev Institute of Physics and Technology, Russian Academy of Sciences, Moscow 117218, Russian Federation
| | - Alexander G Majouga
- D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russian Federation
| | - Vladislav Ya Panchenko
- Lomonosov Moscow State University, Moscow 119991, Russian Federation
- National Research Centre "Kurchatov Institute", Moscow 123182, Russian Federation
| | - Maxim A Abakumov
- National University of Science and Technology MISiS, Moscow 119049, Russian Federation
| |
Collapse
|
20
|
Machulkin AE, Shafikov RR, Uspenskaya AA, Petrov SA, Ber AP, Skvortsov DA, Nimenko EA, Zyk NU, Smirnova GB, Pokrovsky VS, Abakumov MA, Saltykova IV, Akhmirov RT, Garanina AS, Polshakov VI, Saveliev OY, Ivanenkov YA, Aladinskaya AV, Finko AV, Yamansarov EU, Krasnovskaya OO, Erofeev AS, Gorelkin PV, Dontsova OA, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them. J Med Chem 2021; 64:4532-4552. [PMID: 33822606 DOI: 10.1021/acs.jmedchem.0c01935] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II (GCPII), is a suitable target for specific delivery of antitumor drugs and diagnostic agents due to its overexpression in prostate cancer cells. In the current work, we describe the design, synthesis, and biological evaluation of novel low-molecular PSMA ligands and conjugates with fluorescent dyes FAM-5, SulfoCy5, and SulfoCy7. In vitro evaluation of synthesized PSMA ligands on the activity of PSMA shows that the addition of aromatic amino acids into a linker structure leads to a significant increase in inhibition. The conjugates of the most potent ligand with FAM-5 as well as SulfoCy5 demonstrated high affinities to PSMA-expressing tumor cells in vitro. In vivo biodistribution in 22Rv1 xenografts in Balb/c nude mice of PSMA-SulfoCy5 and PSMA-SulfoCy7 conjugates with a novel PSMA ligand demonstrated good visualization of PSMA-expressing tumors. Also, the conjugate PSMA-SulfoCy7 demonstrated the absence of any explicit toxicity up to 87.9 mg/kg.
Collapse
Affiliation(s)
- Aleksei E Machulkin
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Radik R Shafikov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences, GSP-7, Ulitsa Miklukho-Maklaya, 16/10, Moscow 117997, Russian Federation
| | - Anastasia A Uspenskaya
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Stanislav A Petrov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Anton P Ber
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Dmitry A Skvortsov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,Faculty of Biology and Biotechnologies, Higher School of Economics, Myasnitskaya 13, Moscow 101000, Russia
| | - Ekaterina A Nimenko
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Nikolay U Zyk
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Galina B Smirnova
- N.N. Blokhin Cancer Research Center, 24 Kashirskoye sh., Moscow 115478 , Russia
| | - Vadim S Pokrovsky
- N.N. Blokhin Cancer Research Center, 24 Kashirskoye sh., Moscow 115478 , Russia.,RUDN University, Miklukho-Maklaya str. 6, Moscow 117198, Russian Federation
| | - Maxim A Abakumov
- National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation
| | - Irina V Saltykova
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Rauf T Akhmirov
- Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russian Federation
| | - Anastasiia S Garanina
- National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation
| | - Vladimir I Polshakov
- Center for Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Moscow 119991, Russian Federation
| | - Oleg Y Saveliev
- Center for Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Moscow 119991, Russian Federation
| | - Yan A Ivanenkov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,Moscow Institute of Physics and Technology (State University), 9 Institutskiy Lane, Dolgoprudny City, Moscow Region 141700, Russian Federation.,National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation.,The Federal State Unitary Enterprise Dukhov Automatics Research Institute, Moscow 127055, Russia.,Institute of Biochemistry and Genetics Ufa Science Centre Russian Academy of Sciences (IBG RAS), Oktyabrya Prospekt 71, Ufa 450054, Russian Federation
| | - Anastasiya V Aladinskaya
- Moscow Institute of Physics and Technology (State University), 9 Institutskiy Lane, Dolgoprudny City, Moscow Region 141700, Russian Federation
| | - Alexander V Finko
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Emil U Yamansarov
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Olga O Krasnovskaya
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation
| | - Alexander S Erofeev
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation
| | - Petr V Gorelkin
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation
| | - Olga A Dontsova
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences, GSP-7, Ulitsa Miklukho-Maklaya, 16/10, Moscow 117997, Russian Federation
| | - Elena K Beloglazkina
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Nikolay V Zyk
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation
| | - Elena S Khazanova
- Izvarino Pharma LLC, v. Vnukovskoe, Vnukovskoe sh., 5th km., Building 1, Moscow 108817, Russian Federation
| | - Alexander G Majouga
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russian Federation.,National University of Science and Technology MISiS, 9 Leninskiy pr., Moscow 119049, Russian Federation.,Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya sq. 9, Moscow 125047, Russian Federation
| |
Collapse
|
21
|
Nikitin AA, Yurenya AY, Zatsepin TS, Aparin IO, Chekhonin VP, Majouga AG, Farle M, Wiedwald U, Abakumov MA. Magnetic Nanoparticles as a Tool for Remote DNA Manipulations at a Single-Molecule Level. ACS Appl Mater Interfaces 2021; 13:14458-14469. [PMID: 33740372 DOI: 10.1021/acsami.0c21002] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
Remote control of cells and single molecules by magnetic nanoparticles in nonheating external magnetic fields is a perspective approach for many applications such as cancer treatment and enzyme activity regulation. However, the possibility and mechanisms of direct effects of small individual magnetic nanoparticles on such processes in magneto-mechanical experiments still remain unclear. In this work, we have shown remote-controlled mechanical dissociation of short DNA duplexes (18-60 bp) under the influence of nonheating low-frequency alternating magnetic fields using individual 11 nm magnetic nanoparticles. The developed technique allows (1) simultaneous manipulation of millions of individual DNA molecules and (2) evaluation of energies of intermolecular interactions in short DNA duplexes or in other molecules. Finally, we have shown that DNA duplexes dissociation is mediated by mechanical stress and produced by the movement of magnetic nanoparticles in magnetic fields, but not by local overheating. The presented technique opens a new avenue for high-precision manipulation of DNA and generation of biosensors for quantification of energies of intermolecular interaction.
Collapse
Affiliation(s)
- Aleksey A Nikitin
- National University of Science and Technology (MISIS), Moscow 119049, Russia
- M. V. Lomonosov Moscow State University, Moscow 119991, Russia
| | - Anton Yu Yurenya
- M. V. Lomonosov Moscow State University, Moscow 119991, Russia
- National Research Center "Kurchatov Institute", Moscow 123098, Russia
| | - Timofei S Zatsepin
- M. V. Lomonosov Moscow State University, Moscow 119991, Russia
- Skolkovo Institute of Science and Technology, Moscow 121205, Russia
| | - Ilya O Aparin
- Skolkovo Institute of Science and Technology, Moscow 121205, Russia
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, N. I. Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Alexander G Majouga
- National University of Science and Technology (MISIS), Moscow 119049, Russia
- M. V. Lomonosov Moscow State University, Moscow 119991, Russia
- D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia
| | - Michael Farle
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg 47057, Germany
| | - Ulf Wiedwald
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg 47057, Germany
| | - Maxim A Abakumov
- National University of Science and Technology (MISIS), Moscow 119049, Russia
- Department of Medical Nanobiotechnology, N. I. Pirogov Russian National Research Medical University, Moscow 117997, Russia
| |
Collapse
|
22
|
Efremova MV, Bodea SV, Sigmund F, Semkina A, Westmeyer GG, Abakumov MA. Genetically Encoded Self-Assembling Iron Oxide Nanoparticles as a Possible Platform for Cancer-Cell Tracking. Pharmaceutics 2021; 13:pharmaceutics13030397. [PMID: 33809789 PMCID: PMC8002387 DOI: 10.3390/pharmaceutics13030397] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/09/2021] [Accepted: 03/12/2021] [Indexed: 01/15/2023] Open
Abstract
The study of growth and possible metastasis in animal models of tumors would benefit from reliable cell labels for noninvasive whole-organism imaging techniques such as magnetic resonance imaging. Genetically encoded cell-tracking reporters have the advantage that they are contrast-selective for viable cells with intact protein expression machinery. Besides, these reporters do not suffer from dilution during cell division. Encapsulins, which are bacterial protein nanocompartments, can serve as genetically controlled labels for multimodal detection of cells. Such nanocompartments can host various guest molecules inside their lumen. These include, for example, fluorescent proteins or enzymes with ferroxidase activity leading to biomineralization of iron oxide inside the encapsulin nanoshell. The aim of this work was to implement heterologous expression of encapsulin systems from Quasibacillus thermotolerans using the fluorescent reporter protein mScarlet-I and ferroxidase IMEF in the human hepatocellular carcinoma cell line HepG2. The successful expression of self-assembled encapsulin nanocompartments with functional cargo proteins was confirmed by fluorescence microscopy and transmission electron microscopy. Also, coexpression of encapsulin nanoshells, ferroxidase cargo, and iron transporter led to an increase in T2-weighted contrast in magnetic resonance imaging of HepG2 cells. The results demonstrate that the encapsulin cargo system from Q. thermotolerans may be suitable for multimodal imaging of cancer cells and could contribute to further in vitro and in vivo studies.
Collapse
Affiliation(s)
- Maria V. Efremova
- Department of Chemistry & TUM School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; (S.-V.B.); (F.S.); (G.G.W.)
- Institute for Synthetic Biomedicine, Helmholtz Center Munich, 85764 Neuherberg, Germany
- Correspondence: (M.V.E.); (M.A.A.); Tel.: +74-95-638-4465 (M.A.A.)
| | - Silviu-Vasile Bodea
- Department of Chemistry & TUM School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; (S.-V.B.); (F.S.); (G.G.W.)
- Institute for Synthetic Biomedicine, Helmholtz Center Munich, 85764 Neuherberg, Germany
| | - Felix Sigmund
- Department of Chemistry & TUM School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; (S.-V.B.); (F.S.); (G.G.W.)
- Institute for Synthetic Biomedicine, Helmholtz Center Munich, 85764 Neuherberg, Germany
| | - Alevtina Semkina
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
- V.P. Serbskiy National Medical Research Center of Psychiatry and Narcology, 119034 Moscow, Russia
| | - Gil G. Westmeyer
- Department of Chemistry & TUM School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; (S.-V.B.); (F.S.); (G.G.W.)
- Institute for Synthetic Biomedicine, Helmholtz Center Munich, 85764 Neuherberg, Germany
| | - Maxim A. Abakumov
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, 119049 Moscow, Russia
- Correspondence: (M.V.E.); (M.A.A.); Tel.: +74-95-638-4465 (M.A.A.)
| |
Collapse
|
23
|
Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Melnikov PA, Gabashvili AN, Cherkashova EA, Vishnevskiy DA, Kurilo VV, Burunova VV, Semkina AS, Abakumov MA, Gubsky LV, Chekhonin VP, Ahlfors JE, Baklaushev VP, Yarygin KN. Intra-Arterial Stem Cell Transplantation in Experimental Stroke in Rats: Real-Time MR Visualization of Transplanted Cells Starting With Their First Pass Through the Brain With Regard to the Therapeutic Action. Front Neurosci 2021; 15:641970. [PMID: 33737862 PMCID: PMC7960930 DOI: 10.3389/fnins.2021.641970] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 02/08/2021] [Indexed: 12/13/2022] Open
Abstract
Cell therapy is an emerging approach to stroke treatment with a potential to limit brain damage and enhance its restoration after the acute phase of the disease. In this study we tested directly reprogrammed neural precursor cells (drNPC) derived from adult human bone marrow cells in the rat middle cerebral artery occlusion (MCAO) model of acute ischemic stroke using human placenta mesenchymal stem cells (pMSC) as a positive control with previously confirmed efficacy. Cells were infused into the ipsilateral (right) internal carotid artery of male Wistar rats 24 h after MCAO. The main goal of this work was to evaluate real-time distribution and subsequent homing of transplanted cells in the brain. This was achieved by performing intra-arterial infusion directly inside the MRI scanner and allowed transplanted cells tracing starting from their first pass through the brain vessels. Immediately after transplantation, cells were observed in the periphery of the infarct zone and in the brain stem, 15 min later small numbers of cells could be discovered deep in the infarct core and in the contralateral hemisphere, where drNPC were seen earlier and in greater numbers than pMSC. Transplanted cells in both groups could no longer be detected in the rat brain 48-72 h after infusion. Histological and histochemical analysis demonstrated that both the drNPC and pMSC were localized inside blood vessels in close contact with the vascular wall. No passage of labeled cells through the blood brain barrier was observed. Additionally, the therapeutic effects of drNPC and pMSC were compared. Both drNPC and pMSC induced substantial attenuation of neurological deficits evaluated at the 7th and 14th day after transplantation using the modified neurological severity score (mNSS). Some of the effects of drNPC and pMSC, such as the influence on the infarct volume and the survival rate of animals, differed. The results suggest a paracrine mechanism of the positive therapeutic effects of IA drNPC and pMSC infusion, potentially enhanced by the cell-cell interactions. Our data also indicate that the long-term homing of transplanted cells in the brain is not necessary for the brain's functional recovery.
Collapse
Affiliation(s)
- Daria D. Namestnikova
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Radiology and Clinical Physiology Scientific Research Center, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Ilya L. Gubskiy
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Radiology and Clinical Physiology Scientific Research Center, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Veronica A. Revkova
- Cell Technology Laboratory, Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Kirill K. Sukhinich
- Laboratory of Problems of Regeneration, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia
| | - Pavel A. Melnikov
- Cell Technology Laboratory, Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
- Department of Fundamental and Applied Neurobiology, Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of Healthcare of Russian Federation, Moscow, Russia
| | - Anna N. Gabashvili
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology “MISIS”, Moscow, Russia
| | - Elvira A. Cherkashova
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Radiology and Clinical Physiology Scientific Research Center, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Daniil A. Vishnevskiy
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
| | - Victoria V. Kurilo
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
| | - Veronica V. Burunova
- Laboratory of Cell Biology, Orekhovich Institute of Biomedical Chemistry of the Russian Academy of Sciences, Moscow, Russia
| | - Alevtina S. Semkina
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology “MISIS”, Moscow, Russia
| | - Maxim A. Abakumov
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology “MISIS”, Moscow, Russia
| | - Leonid V. Gubsky
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Radiology and Clinical Physiology Scientific Research Center, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Vladimir P. Chekhonin
- Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russian Federation, Moscow, Russia
- Department of Fundamental and Applied Neurobiology, Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of Healthcare of Russian Federation, Moscow, Russia
| | | | - Vladimir P. Baklaushev
- Cell Technology Laboratory, Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russian Federation, Moscow, Russia
| | - Konstantin N. Yarygin
- Laboratory of Cell Biology, Orekhovich Institute of Biomedical Chemistry of the Russian Academy of Sciences, Moscow, Russia
- Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| |
Collapse
|
24
|
Pershina AG, Brikunova OY, Demin AM, Abakumov MA, Vaneev AN, Naumenko VA, Erofeev AS, Gorelkin PV, Nizamov TR, Muslimov AR, Timin AS, Malkeyeva D, Kiseleva E, Vtorushin SV, Larionova IV, Gereng EA, Minin AS, Murzakaev AM, Krasnov VP, Majouga AG, Ogorodova LM. Variation in tumor pH affects pH-triggered delivery of peptide-modified magnetic nanoparticles. Nanomedicine 2021; 32:102317. [PMID: 33096245 DOI: 10.1016/j.nano.2020.102317] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 09/11/2020] [Accepted: 10/07/2020] [Indexed: 01/27/2023]
Abstract
Acidification of the extracellular matrix, an intrinsic characteristic of many solid tumors, is widely exploited for physiologically triggered delivery of contrast agents, drugs, and nanoparticles to tumor. However, pH of tumor microenvironment shows intra- and inter-tumor variation. Herein, we investigate the impact of this variation on pH-triggered delivery of magnetic nanoparticles (MNPs) modified with pH-(low)-insertion peptide (pHLIP). Fluorescent flow cytometry, laser confocal scanning microscopy and transmission electron microscopy data proved that pHLIP-conjugated MNPs interacted with 4T1 cells in two-dimensional culture and in spheroids more effectively at pH 6.4 than at pH 7.2, and entered the cell via clathrin-independent endocytosis. The accumulation efficiency of pHLIP-conjugated MNPs in 4T1 tumors after their intravenous injection, monitored in vivo by magnetic resonance imaging, showed variation. Analysis of the tumor pH profiles recorded with implementation of original nanoprobe pH sensor, revealed obvious correlation between pH measured in the tumor with the amount of accumulated MNPs.
Collapse
Affiliation(s)
- Alexandra G Pershina
- Siberian State Medical University, Tomsk, Russia; Research School of Chemical and Biomedical Engineering, National Research Tomsk Polytechnic University, Tomsk, Russia.
| | | | - Alexander M Demin
- Postovsky Institute of Organic Synthesis UB RAS, Yekaterinburg, Russia
| | - Maxim A Abakumov
- National University of Science and Technology MISiS, Moscow, Russia
| | - Alexander N Vaneev
- National University of Science and Technology MISiS, Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia
| | - Victor A Naumenko
- National University of Science and Technology MISiS, Moscow, Russia; V. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russia
| | - Alexander S Erofeev
- National University of Science and Technology MISiS, Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia
| | - Peter V Gorelkin
- National University of Science and Technology MISiS, Moscow, Russia; Medical Nanotechnology LLC, Moscow, Russia
| | - Timur R Nizamov
- National University of Science and Technology MISiS, Moscow, Russia
| | - Albert R Muslimov
- Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia
| | - Alexander S Timin
- Research School of Chemical and Biomedical Engineering, National Research Tomsk Polytechnic University, Tomsk, Russia; Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia
| | - Dina Malkeyeva
- Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
| | - Elena Kiseleva
- Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
| | - Sergey V Vtorushin
- Siberian State Medical University, Tomsk, Russia; Cancer Research Institute, Tomsk National Research Medical Center RAS, Tomsk, Russia
| | - Irina V Larionova
- Cancer Research Institute, Tomsk National Research Medical Center RAS, Tomsk, Russia; National Research Tomsk State University, Tomsk, Russia
| | | | - Artem S Minin
- Mikheev Institute of Metal Physics UB RAS, Yekaterinburg, Russia
| | - Aidar M Murzakaev
- Institute of Electrophysics UB RAS, Yekaterinburg, Russia; Ural Federal University, Yekaterinburg, Russia
| | - Victor P Krasnov
- Postovsky Institute of Organic Synthesis UB RAS, Yekaterinburg, Russia; Ural Federal University, Yekaterinburg, Russia
| | - Alexander G Majouga
- National University of Science and Technology MISiS, Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia
| | | |
Collapse
|
25
|
Naumenko VA, Vodopyanov SS, Vlasova KY, Potashnikova DM, Melnikov PA, Vishnevskiy DA, Garanina AS, Valikhov MP, Lipatova AV, Chekhonin VP, Majouga AG, Abakumov MA. Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy. J Control Release 2021; 330:244-256. [DOI: 10.1016/j.jconrel.2020.12.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 10/29/2020] [Accepted: 12/11/2020] [Indexed: 01/04/2023]
|
26
|
Gabashvili AN, Chmelyuk NS, Efremova MV, Malinovskaya JA, Semkina AS, Abakumov MA. Encapsulins-Bacterial Protein Nanocompartments: Structure, Properties, and Application. Biomolecules 2020; 10:biom10060966. [PMID: 32604934 PMCID: PMC7355545 DOI: 10.3390/biom10060966] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 06/21/2020] [Accepted: 06/23/2020] [Indexed: 02/07/2023] Open
Abstract
Recently, a new class of prokaryotic compartments, collectively called encapsulins or protein nanocompartments, has been discovered. The shell proteins of these structures self-organize to form icosahedral compartments with a diameter of 25-42 nm, while one or more cargo proteins with various functions can be encapsulated in the nanocompartment. Non-native cargo proteins can be loaded into nanocompartments and the surface of the shells can be further functionalized, which allows for developing targeted drug delivery systems or using encapsulins as contrast agents for magnetic resonance imaging. Since the genes encoding encapsulins can be integrated into the cell genome, encapsulins are attractive for investigation in various scientific fields, including biomedicine and nanotechnology.
Collapse
Affiliation(s)
- Anna N. Gabashvili
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (N.S.C.)
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova st, 1, 117997 Moscow, Russia;
| | - Nelly S. Chmelyuk
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (N.S.C.)
| | - Maria V. Efremova
- Department of Nuclear Medicine, TUM School of Medicine, Technical University of Munich, 81675 Munich, Germany;
- Institute of Biological and Medical Imaging and Institute of Developmental Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany
| | | | - Alevtina S. Semkina
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova st, 1, 117997 Moscow, Russia;
| | - Maxim A. Abakumov
- Laboratory “Biomedical Nanomaterials”, National University of Science and Technology “MISiS”, Leninskiy Prospect, 4, 119049 Moscow, Russia; (A.N.G.); (N.S.C.)
- Department of Medical Nanobiotechnoilogy, Pirogov Russian National Research Medical University, Ostrovityanova st, 1, 117997 Moscow, Russia;
- Correspondence: ; Tel.: +7-903-586-4777
| |
Collapse
|
27
|
Vaneev AN, Gorelkin PV, Garanina AS, Lopatukhina HV, Vodopyanov SS, Alova AV, Ryabaya OO, Akasov RA, Zhang Y, Novak P, Salikhov SV, Abakumov MA, Takahashi Y, Edwards CRW, Klyachko NL, Majouga AG, Korchev YE, Erofeev AS. In Vitro and In Vivo Electrochemical Measurement of Reactive Oxygen Species After Treatment with Anticancer Drugs. Anal Chem 2020; 92:8010-8014. [PMID: 32441506 DOI: 10.1021/acs.analchem.0c01256] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
In vivo monitoring of reactive oxygen species (ROS) in tumors during treatment with anticancer therapy is important for understanding the mechanism of action and in the design of new anticancer drugs. In this work, a platinized nanoelectrode is placed into a single cell for detection of the ROS signal, and drug-induced ROS production is then recorded. The main advantages of this method are the short incubation time with the drug and its high sensitivity which allows the detection of low intracellular ROS concentrations. We have shown that our new method can measure the ROS response to chemotherapy in tumor-bearing mice in real-time. ROS levels were measured in vivo inside the tumor at different depths in response to doxorubicin. This work provides an effective new approach for the measurement of intracellular ROS by platinized nanoelectrodes.
Collapse
Affiliation(s)
- Alexander N Vaneev
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| | - Petr V Gorelkin
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia
| | - Anastasiia S Garanina
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia
| | - Helena V Lopatukhina
- Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| | - Stepan S Vodopyanov
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| | - Anna V Alova
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| | - Oxana O Ryabaya
- N. N. Blokhin National Medical Research Center of Oncology, 24 Kashirskoe shosse, Moscow 115478, Russia
| | - Roman A Akasov
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,I. M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, Moscow 119991, Russia
| | - Yanjun Zhang
- Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.,Imperial College London, Department of Medicine, London W12 0NN, United Kingdom
| | - Pavel Novak
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Imperial College London, Department of Medicine, London W12 0NN, United Kingdom
| | - Sergey V Salikhov
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia
| | - Maxim A Abakumov
- N. I. Pirogov Russian National Research Medical University, Ostrovityanova Street 1/7, Moscow 117997, Russia
| | - Yasufumi Takahashi
- Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
| | | | - Natalia L Klyachko
- Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| | - Alexander G Majouga
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia.,D. Mendeleev University of Chemical Technology of Russia, Miusskaya Square, 9, Moscow 125047, Russia
| | - Yuri E Korchev
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Imperial College London, Department of Medicine, London W12 0NN, United Kingdom
| | - Alexander S Erofeev
- National University of Science and Technology "MISiS", Leninskiy Avenue, 4, Moscow 119049, Russia.,Lomonosov Moscow State University, Chemistry Department, Leninskie Gory, 1, 3, Moscow 119991, Russia
| |
Collapse
|
28
|
Nalench YA, Shchetinin IV, Skorikov AS, Mogilnikov PS, Farle M, Savchenko AG, Majouga AG, Abakumov MA, Wiedwald U. Unravelling the nucleation, growth, and faceting of magnetite-gold nanohybrids. J Mater Chem B 2020; 8:3886-3895. [PMID: 32227007 DOI: 10.1039/c9tb02721a] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The chemical synthesis of nanoparticles with a preassigned size and shape is important for an optimized performance in any application. Therefore, systematic monitoring of the synthesis is required for the control and detailed understanding of the nucleation and growth of the nanoparticles. Here, we study Fe3O4-Au hybrid nanoparticles in detail using probes of the reaction mixture during synthesis and their thorough characterization. The proposed approach eliminates the problem of repeatability and reproducibility of the chemical synthesis and was carried out using laboratory equipment (standard transmission electron microscopy, X-ray diffraction, and magnetometry) for typically 10 μL samples instead of, for example, a dedicated synthesis and inspection at a synchrotron radiation facility. From the three independent experimental techniques we extract the nanoparticle size at 12 stages of the synthesis. These diameters show identical trends and good quantitative agreement. Two consecutive processes occur during the synthesis of Fe3O4-Au nanoparticles, the nucleation and the growth of spherical Fe3O4 nanoparticles on the surface of Au seeds during the heating stage and their faceting towards octahedral shape during reflux. The final nanoparticles with sizes of 15 nm Fe3O4 and 4 nm Au exhibit superparamagnetic behavior at ambient temperature. These are high-quality, close to stoichiometric Fe3O4 nanocrystals with nearly volumetric magnetic behavior as confirmed by the presence of the Verwey transition. Understanding the processes occurring during the synthesis allows the nanoparticle size and shape to be adjusted, improving their capabilities in biomedical applications.
Collapse
Affiliation(s)
- Yulia A Nalench
- National University of Science and Technology "MISIS", Moscow, 119049, Russia and Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russia.
| | - Igor V Shchetinin
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
| | | | - Pavel S Mogilnikov
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
| | - Michael Farle
- Faculty of Physics and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Duisburg, 47057, Germany.
| | | | - Alexander G Majouga
- National University of Science and Technology "MISIS", Moscow, 119049, Russia and Lomonosov Moscow State University, Moscow, 119991, Russia and D. Mendeleev University of Chemical Technology of Russia, Moscow, 125047, Russia
| | - Maxim A Abakumov
- National University of Science and Technology "MISIS", Moscow, 119049, Russia and Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russia.
| | - Ulf Wiedwald
- National University of Science and Technology "MISIS", Moscow, 119049, Russia and Faculty of Physics and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Duisburg, 47057, Germany.
| |
Collapse
|
29
|
Vlasova KY, Vishwasrao H, Abakumov MA, Golovin DY, Gribanovsky SL, Zhigachev AO, Poloznikov AА, Majouga AG, Golovin YI, Sokolsky-Papkov M, Klyachko NL, Kabanov AV. Enzyme Release from Polyion Complex by Extremely Low Frequency Magnetic Field. Sci Rep 2020; 10:4745. [PMID: 32179787 PMCID: PMC7076007 DOI: 10.1038/s41598-020-61364-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Accepted: 12/11/2019] [Indexed: 01/12/2023] Open
Abstract
Remote nano-magneto-mechanical actuation of magnetic nanoparticles (MNPs) by non-heating extremely low frequency magnetic field (ELF MF) is explored as a tool for non-invasive modification of bionanomaterials in pharmaceutical and medical applications. Here we study the effects of ELF MF (30-160 Hz, 8-120 kA/m) on the activity and release of a model enzyme, superoxide dismutase 1 (SOD1) immobilized by polyion coupling on dispersed MNPs aggregates coated with poly(L-lysine)-block-poly(ethylene glycol) block copolymer (s-MNPs). Such fields do not cause any considerable heating of MNPs but promote their rotating-oscillating mechanical motion that produces mechanical forces and deformations in adjacent materials. We observed the changes in the catalytic activity of immobilized SOD1 as well as its release from the s-MNPs/SOD1 polyion complex upon application of the ELF MF for 5 to 15 min. At longer exposures (25 min) the s-MNPs/SOD1 dispersion destabilizes. The bell-shaped effect of the field frequency with maximum at f = 50 Hz and saturation effect of field strength (between 30 kA/m and 120 kA/m at f = 50 Hz) are reported and explained. The findings are significant as one early indication of the nano-magneto-mechanical disruption by ELF MF of cooperative polyion complexes that are widely used for design of current functional healthcare bionanomaterials.
Collapse
Affiliation(s)
- Kseniya Yu Vlasova
- Laboratory for Chemical Design of Bionanomaterials, School of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
| | - Hemant Vishwasrao
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA
| | - Maxim A Abakumov
- National University of Science and Technology MISIS, Moscow, 119049, Russia
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | | | | | | | - Andrey А Poloznikov
- FSBI National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, 249036, Russia
| | - Alexander G Majouga
- Laboratory for Chemical Design of Bionanomaterials, School of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- National University of Science and Technology MISIS, Moscow, 119049, Russia
- D. Mendeleev University of Chemical Technology of Russia, Moscow, 125047, Russia
| | - Yuri I Golovin
- Laboratory for Chemical Design of Bionanomaterials, School of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- G.R. Derzhavin Tambov State University, Tambov, 392036, Russia
| | - Marina Sokolsky-Papkov
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA
| | - Natalia L Klyachko
- Laboratory for Chemical Design of Bionanomaterials, School of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA
- G.R. Derzhavin Tambov State University, Tambov, 392036, Russia
| | - Alexander V Kabanov
- Laboratory for Chemical Design of Bionanomaterials, School of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia.
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
| |
Collapse
|
30
|
Garanina AS, Naumenko VA, Nikitin AA, Myrovali E, Petukhova AY, Klimyuk SV, Nalench YA, Ilyasov AR, Vodopyanov SS, Erofeev AS, Gorelkin PV, Angelakeris M, Savchenko AG, Wiedwald U, Majouga Dr AG, Abakumov MA. Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination. Nanomedicine 2020; 25:102171. [PMID: 32084594 DOI: 10.1016/j.nano.2020.102171] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Revised: 12/30/2019] [Accepted: 02/03/2020] [Indexed: 02/08/2023]
Abstract
Magnetic hyperthermia (MHT) is a promising approach for cancer therapy. However, a systematic MHT characterization as function of temperature on the therapeutic efficiency is barely analyzed. Here, we first perform comparative temperature-dependent analysis of the cobalt ferrite nanoparticles-mediated MHT effectiveness in two murine tumors models - breast (4T1) and colon (CT26) cancer in vitro and in vivo. The overall MHT killing capacity in vitro increased with the temperature and CT26 cells were more sensitive than 4T1 when heated to 43 °C. Well in line with the in vitro data, such heating cured non-metastatic CT26 tumors in vivo, while only inhibiting metastatic 4T1 tumor growth without improving the overall survival. High-temperature MHT (>47 °C) resulted in complete 4T1 primary tumor clearance, 25-40% long-term survival rates, and, importantly, more effective prevention of metastasis comparing to surgical extraction. Thus, the specific MHT temperature must be defined for each tumor individually to ensure a successful antitumor therapy.
Collapse
Affiliation(s)
- Anastasiia S Garanina
- National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia.
| | - Victor A Naumenko
- National University of Science and Technology «MISiS», Moscow, Russia; National Medical Research Center for Psychiatry and Narcology, Moscow, Russia
| | - Aleksey A Nikitin
- National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia
| | - Eirini Myrovali
- School of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Anna Y Petukhova
- National University of Science and Technology «MISiS», Moscow, Russia
| | | | - Yulia A Nalench
- National University of Science and Technology «MISiS», Moscow, Russia
| | - Artem R Ilyasov
- National University of Science and Technology «MISiS», Moscow, Russia
| | | | - Alexander S Erofeev
- National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia
| | - Peter V Gorelkin
- Medical Nanotechnology LLC, Skolkovo Innovation Center, Moscow, Russia
| | - Makis Angelakeris
- School of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | | | - Ulf Wiedwald
- National University of Science and Technology «MISiS», Moscow, Russia; Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, Germany
| | - Alexander G Majouga Dr
- National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia; D. Mendeleev University of Chemical Technology of Russia, Moscow, Russia
| | - Maxim A Abakumov
- National University of Science and Technology «MISiS», Moscow, Russia; Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, Russia
| |
Collapse
|
31
|
Kapitanova KS, Naumenko VA, Garanina AS, Melnikov PA, Abakumov MA, Alieva IB. Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy. Biochemistry (Mosc) 2019; 84:729-745. [PMID: 31509725 DOI: 10.1134/s0006297919070058] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Despite the progress of modern medicine, oncological diseases are still among the most common causes of death of adult populations in developed countries. The current therapeutic approaches are imperfect, and the high mortality of oncological patients under treatment, the lack of personalized strategies, and severe side effects arising as a result of treatment force seeking new approaches to therapy of malignant tumors. During the last decade, cancer immunotherapy, an approach that relies on activation of the host antitumor immune response, has been actively developing. Cancer immunotherapy is the most promising trend in contemporary fundamental and practical oncology, and restoration of the pathologically altered tumor microenvironment is one of its key tasks, in particular, the reprogramming of tumor macrophages from the immunosuppressive M2-phenotype into the proinflammatory M1-phenotype is pivotal for eliciting antitumor response. This review describes the current knowledge about macrophage classification, mechanisms of their polarization, their role in formation of the tumor microenvironment, and strategies for changing the functional activity of M2-macrophages, as well as problems of targeted delivery of immunostimulatory signals to tumor macrophages using nanoparticles.
Collapse
Affiliation(s)
- K S Kapitanova
- Lomonosov Moscow State University, Department of Bioengineering and Bioinformatics, Moscow, 119991, Russia
| | - V A Naumenko
- National University of Science and Technology "MISIS", Moscow, 119049, Russia.
| | - A S Garanina
- National University of Science and Technology "MISIS", Moscow, 119049, Russia
| | - P A Melnikov
- Serbsky Federal Medical Research Center of Psychiatry and Narcology, Department of Fundamental and Applied Neurobiology, Ministry of Health of the Russian Federation, Moscow, 119034, Russia
| | - M A Abakumov
- National University of Science and Technology "MISIS", Moscow, 119049, Russia.,Russian National Research Medical University, Department of Medical Nanobiotechnology, Moscow, 117997, Russia
| | - I B Alieva
- A. N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia.
| |
Collapse
|
32
|
Naumenko VA, Vlasova KY, Garanina AS, Melnikov PA, Potashnikova DM, Vishnevskiy DA, Vodopyanov SS, Chekhonin VP, Abakumov MA, Majouga AG. Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors. ACS Nano 2019; 13:12599-12612. [PMID: 31609576 DOI: 10.1021/acsnano.9b03848] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Liposomes are the most extensively used nanocarriers in cancer therapy. Despite the advantages these vehicles provide over free drugs, there are still limitations with regards to the efficiency of liposomes delivery to tumors and off-target accumulation. A better understanding of nanodrugs extravasation mechanisms in different tumor types and normal vessels is needed to improve their antitumor activity. We used intravital microscopy to track for fluorescent liposomes behavior in xenograft tumor models (murine breast cancer 4T1 and melanoma B16, human prostate cancer 22Rv1) and normal skin and identified two distinct extravasation patterns. Microleakage, a local perivascular nanoparticle deposition, was found both in malignant and healthy tissues. This type of liposomes leakage does not provide access to tumor cells and is presumably responsible for drug deposition in normal tissues. In contrast, macroleakage penetrated deep into tissues and localized predominantly on the tumor-host interface. Although neutrophils did not uptake liposomes, their extravasation appeared to initiate both micro- and macroleakages. Based on neutrophils and liposomes extravasation dynamics, we hypothesized that microleakage and macroleakage are subsequent steps of the extravasation process corresponding to liposomes transport through endothelial and subendothelial barriers. Of note, extravasation spots were detected more often in the proximity of neutrophils, and across studied tumor types, neutrophils counts correlated with leakage frequencies. Reduced liposomes accumulation in 4T1 tumors upon Ly6G depletion further corroborated neutrophils role in nanoparticles delivery. Elucidating liposomes extravasation routes has a potential to help improve existing strategies and develop effective nanodrugs for cancer therapy.
Collapse
Affiliation(s)
- Victor A Naumenko
- National University of Science and Technology (MISIS) , Moscow 119049 , Russia
| | - Kseniya Yu Vlasova
- School of Chemistry , M. V. Lomonosov Moscow State University , Moscow 119991 , Russia
| | | | - Pavel A Melnikov
- Department of Medical Nanobiotechnology , N. I. Pirogov Russian National Research Medical University , Moscow 117997 , Russia
| | - Daria M Potashnikova
- School of Biology, Department of Cell Biology and Histology , M. V. Lomonosov Moscow State University , Moscow 119234 , Russia
| | - Daniil A Vishnevskiy
- Department of Medical Nanobiotechnology , N. I. Pirogov Russian National Research Medical University , Moscow 117997 , Russia
| | - Stepan S Vodopyanov
- National University of Science and Technology (MISIS) , Moscow 119049 , Russia
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology , N. I. Pirogov Russian National Research Medical University , Moscow 117997 , Russia
| | - Maxim A Abakumov
- National University of Science and Technology (MISIS) , Moscow 119049 , Russia
- Department of Medical Nanobiotechnology , N. I. Pirogov Russian National Research Medical University , Moscow 117997 , Russia
| | - Alexander G Majouga
- National University of Science and Technology (MISIS) , Moscow 119049 , Russia
- D. Mendeleev University of Chemical Technology of Russia , Moscow 125047 , Russia
| |
Collapse
|
33
|
Gervits NE, Gippius AA, Tkachev AV, Demikhov EI, Starchikov SS, Lyubutin IS, Vasiliev AL, Chekhonin VP, Abakumov MA, Semkina AS, Mazhuga AG. Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents. Beilstein J Nanotechnol 2019; 10:1964-1972. [PMID: 31667044 PMCID: PMC6808196 DOI: 10.3762/bjnano.10.193] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2019] [Accepted: 09/08/2019] [Indexed: 06/10/2023]
Abstract
Background: One of the future applications of magnetic nanoparticles is the development of new iron-oxide-based magnetic resonance imaging (MRI) negative contrast agents, which are intended to improve the results of diagnostics and complement existing Gd-based contrast media. Results: Iron oxide nanoparticles designed for use as MRI contrast media are precisely examined by a variety of methods: powder X-ray diffraction (XRD), transmission electron microscopy (TEM), Raman spectroscopy, Mössbauer spectroscopy and zero-field nuclear magnetic resonance (ZF-NMR) spectroscopy. TEM and XRD measurements reveal a spherical shape of the nanoparticles with an average diameter of 5-8 nm and a cubic spinel-type crystal structure of space group Fd-3m. Raman, Mössbauer and NMR spectroscopy clearly indicate the presence of the maghemite γ-Fe2O3 phase. Moreover, a difference in the magnetic behavior of uncoated and human serum albumin coated iron oxide nanoparticles was observed by Mössbauer spectroscopy. Conclusion: This difference in magnetic behavior is explained by the influence of biofunctionalization on the magnetic and electronic properties of the iron oxide nanoparticles. The ZF-NMR spectra analysis allowed us to determine the relative amount of iron located in the core and the surface layer of the nanoparticles. The obtained results are important for understanding the structural and magnetic properties of iron oxide nanoparticles used as T 2 contrast agents for MRI.
Collapse
Affiliation(s)
- Natalia E Gervits
- Shubnikov Institute of Crystallography of FSRC “Crystallography and Photonics” RAS, 119333, Moscow, Russia
- Lebedev Physical Institute, Russian Academy of Sciences, 119991, Moscow, Russia
| | - Andrey A Gippius
- Lebedev Physical Institute, Russian Academy of Sciences, 119991, Moscow, Russia
- Moscow State University, Physical Department, 119992, Moscow, Russia
| | - Alexey V Tkachev
- Lebedev Physical Institute, Russian Academy of Sciences, 119991, Moscow, Russia
| | - Evgeniy I Demikhov
- Lebedev Physical Institute, Russian Academy of Sciences, 119991, Moscow, Russia
| | - Sergey S Starchikov
- Shubnikov Institute of Crystallography of FSRC “Crystallography and Photonics” RAS, 119333, Moscow, Russia
| | - Igor S Lyubutin
- Shubnikov Institute of Crystallography of FSRC “Crystallography and Photonics” RAS, 119333, Moscow, Russia
| | - Alexander L Vasiliev
- Shubnikov Institute of Crystallography of FSRC “Crystallography and Photonics” RAS, 119333, Moscow, Russia
- National Research Center "Kurchatov Institute", 123182, Moscow, Russia
- Moscow Institute of Physics and Technology (State University), MIPT, 141701 Moscow Region, Russia
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Maxim A Abakumov
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia
- Laboratory of Biomedical Nanomaterials, NUST MISiS, Moscow Russia
| | - Alevtina S Semkina
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia
- Laboratory of Biomedical Nanomaterials, NUST MISiS, Moscow Russia
| | - Alexander G Mazhuga
- Laboratory of Biomedical Nanomaterials, NUST MISiS, Moscow Russia
- Mendeleev Chemical Technological University, Moscow, Russia
| |
Collapse
|
34
|
Voronova АD, Stepanova OV, Valikhov MP, Chadin AV, Semkina АS, Abakumov MA, Reshetov IV, Chekhonin VP. Comparison of the Efficiency of Transplantation of Rat and Human Olfactory Ensheathing Cells in Posttraumatic Cysts of the Spinal Cord. Bull Exp Biol Med 2019; 167:536-540. [PMID: 31502130 DOI: 10.1007/s10517-019-04568-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2018] [Indexed: 11/24/2022]
Abstract
Olfactory ensheathing cells showed significant effects on the regeneration of the spinal cord in experimental models and in clinical trials. However, the use of these cells in the therapy of posttraumatic cysts of the spinal cord has not been studied. Cultures of human and rat olfactory mucosa were obtained according to the protocols developed by us. Passage 3-4 cultures are most enriched with olfactory ensheathing cells and are preferable for transplantation. We performed transplantation of 750,000 olfactory ensheathing cells into the region of modeled cysts. The therapeutic effect of human cells was more pronounced. The positive dynamics of recovery of motor activity in the hind limbs of rats can reflect regenerative processes in the spinal cord after transplantation of olfactory ensheathing cells into the region of posttraumatic cysts.
Collapse
Affiliation(s)
- А D Voronova
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia. .,Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
| | - O V Stepanova
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M P Valikhov
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A V Chadin
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - А S Semkina
- Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M A Abakumov
- Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - I V Reshetov
- University Hospital No. 1, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Chekhonin
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.,Department of Medical Nanobiotechnologies, Medical and Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
35
|
Vodopyanov SS, Kunin MA, Garanina AS, Grinenko NF, Vlasova KY, Mel'nikov PA, Chekhonin VP, Sukhinich KK, Makarov AV, Naumenko VA, Abakumov MA, Majouga AG. Preparation and Testing of Cells Expressing Fluorescent Proteins for Intravital Imaging of Tumor Microenvironment. Bull Exp Biol Med 2019; 167:123-130. [PMID: 31183645 DOI: 10.1007/s10517-019-04475-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Indexed: 10/26/2022]
Abstract
Intravital microscopy is widely used for in vivo studies of the mechanisms of carcinogenesis and response to antitumor therapy. For visualization of tumor cells in vivo, cell lines expressing fluorescent proteins are needed. Expression of exogenous proteins can affect cell growth rate and their tumorigenic potential. Therefore, comprehensive analysis of the morphofunctional properties of transduced cells is required for creating appropriate models of tumor microenvironment. In the present study, six lines of mouse tumor cells expressing green and red fluorescent proteins were derived. Analysis of cells morphology, growth kinetics, and response to chemotherapy in vitro revealed no significant differences between wild-type and transduced cell lines. Introduction of fluorescent proteins into the genome of 4T1 (murine breast cancer) and B16-F10 (murine melanoma) cells did not affect tumor growth rate after subcutaneous implantation to mice, while both CT26-GFP and CT26-RFP cells (murine colon cancer) were rejected starting from day 8 after implantation. Elucidation of the mechanisms underlying CT26-GFP/RFP rejection is required to modify transduction technique for creating the models of tumor microenvironment accessible for in vivo visualization. Transduced 4T1 and B16-F10 cell lines can be used for intravital microscopic imaging of tumor cells, neoplastic vasculature, and leukocyte subpopulations.
Collapse
Affiliation(s)
- S S Vodopyanov
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow, Russia.
| | - M A Kunin
- M. V. Lomonosov Moscow State University, Moscow, Russia
| | - A S Garanina
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow, Russia
| | - N F Grinenko
- V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - K Yu Vlasova
- M. V. Lomonosov Moscow State University, Moscow, Russia
| | - P A Mel'nikov
- V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Chekhonin
- V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - K K Sukhinich
- N. K. Kol'tsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia
| | - A V Makarov
- V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V A Naumenko
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow, Russia
| | - M A Abakumov
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow, Russia
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A G Majouga
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology (MISIS), Moscow, Russia
- M. V. Lomonosov Moscow State University, Moscow, Russia
- D. I. Mendeleev University of Chemical Technology, Moscow, Russia
| |
Collapse
|
36
|
Lipengolts AA, Vorobyeva ES, Cherepanov AA, Abakumov MA, Abakumova TO, Smirnova AV, Finogenova Y, Grigorieva EY, Sheino IN, Kulakov VN. Evaluation of absorbed dose distribution in melanoma B16F10 during contrast enhanced radiotherapy with intratumoral administration of dose-enhancing agent. BRSMU 2018. [DOI: 10.24075/brsmu.2018.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Contrast-enhanced radiotherapy (CERT) is a binary treatment modality in which the absorbed radiation dose is not only determined by the parameters of the external radiation source but also affected by the concentration of a dose-enhancing agent (DEA) in the studied object. In this work we assessed the distribution of the absorbed dose in a murine B16F10 melanoma injected with a single dose of an aqueous Bi-DTPA solution. The mice were exposed to a single fraction of X-ray irradiation for 28.5 min. In vivo measurements of DEA concentrations were done on a micro-CT scanner using the radiopacity values of malignant tissues from the obtained CT images. We found that the presence of DEA enhanced the absorbed dose more than twofold in 6% of the tumor volume; in 29% of the tumor volume the absorbed dose increased more than onefold. The tumor growth delay time calculated for our model was 0.76 days (we only accounted for the damage caused directly by radiation), whereas in our previous research study tumor growth delay was 10 days. This discrepancy may indicate that in the tumors exposed to contrast-enhanced radiotherapy growth delay results from both the damage directly caused by radiation and other antitumor mechanisms.
Collapse
Affiliation(s)
- AA Lipengolts
- Blokhin National Medical Research Center of Oncology, Moscow; A. I. Burnazyan Federal Medical Biophysical Center, Moscow; Kurnakov Institute of General and Inorganic Chemistry, Moscow
| | - ES Vorobyeva
- A. I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
| | - AA Cherepanov
- Blokhin National Medical Research Center of Oncology, Moscow
| | - MA Abakumov
- Pirogov Russian National Research Medical University, Moscow; National University of Science and Technology "MISiS", Moscow
| | - TO Abakumova
- Skolkovo Institute of Science and Technology, Moscow
| | - AV Smirnova
- Blokhin National Medical Research Center of Oncology, Moscow; The Loginov Moscow Clinical Scientific Center, Moscow
| | - YuA Finogenova
- Pirogov Russian National Research Medical University, Moscow, Russia
| | - EYu Grigorieva
- Blokhin National Medical Research Center of Oncology, Moscow; Kurnakov Institute of General and Inorganic Chemistry, Moscow
| | - IN Sheino
- A. I. Burnazyan Federal Medical Biophysical Center, Moscow
| | - VN Kulakov
- A. I. Burnazyan Federal Medical Biophysical Center, Moscow
| |
Collapse
|
37
|
Efremova MV, Nalench YA, Myrovali E, Garanina AS, Grebennikov IS, Gifer PK, Abakumov MA, Spasova M, Angelakeris M, Savchenko AG, Farle M, Klyachko NL, Majouga AG, Wiedwald U. Size-selected Fe 3O 4-Au hybrid nanoparticles for improved magnetism-based theranostics. Beilstein J Nanotechnol 2018; 9:2684-2699. [PMID: 30416920 PMCID: PMC6204820 DOI: 10.3762/bjnano.9.251] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Accepted: 09/17/2018] [Indexed: 05/24/2023]
Abstract
Size-selected Fe3O4-Au hybrid nanoparticles with diameters of 6-44 nm (Fe3O4) and 3-11 nm (Au) were prepared by high temperature, wet chemical synthesis. High-quality Fe3O4 nanocrystals with bulk-like magnetic behavior were obtained as confirmed by the presence of the Verwey transition. The 25 nm diameter Fe3O4-Au hybrid nanomaterial sample (in aqueous and agarose phantom systems) showed the best characteristics for application as contrast agents in magnetic resonance imaging and for local heating using magnetic particle hyperthermia. Due to the octahedral shape and the large saturation magnetization of the magnetite particles, we obtained an extraordinarily high r 2-relaxivity of 495 mM-1·s-1 along with a specific loss power of 617 W·gFe -1 and 327 W·gFe -1 for hyperthermia in aqueous and agarose systems, respectively. The functional in vitro hyperthermia test for the 4T1 mouse breast cancer cell line demonstrated 80% and 100% cell death for immediate exposure and after precultivation of the cells for 6 h with 25 nm Fe3O4-Au hybrid nanomaterials, respectively. This confirms that the improved magnetic properties of the bifunctional particles present a next step in magnetic-particle-based theranostics.
Collapse
Affiliation(s)
- Maria V Efremova
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Yulia A Nalench
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Eirini Myrovali
- Physics Department, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece
| | - Anastasiia S Garanina
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Ivan S Grebennikov
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Polina K Gifer
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Maxim A Abakumov
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
- Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russia
| | - Marina Spasova
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen (CENIDE), Duisburg, 47057, Germany
| | - Makis Angelakeris
- Physics Department, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece
| | | | - Michael Farle
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen (CENIDE), Duisburg, 47057, Germany
| | - Natalia L Klyachko
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
| | - Alexander G Majouga
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
- D. Mendeleev University of Chemical Technology of Russia, Moscow, 125047, Russia
| | - Ulf Wiedwald
- National University of Science and Technology «MISIS», Moscow, 119049, Russia
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen (CENIDE), Duisburg, 47057, Germany
| |
Collapse
|
38
|
Abakumov MA, Semkina AS, Skorikov AS, Vishnevskiy DA, Ivanova AV, Mironova E, Davydova GA, Majouga AG, Chekhonin VP. Toxicity of iron oxide nanoparticles: Size and coating effects. J Biochem Mol Toxicol 2018; 32:e22225. [PMID: 30290022 DOI: 10.1002/jbt.22225] [Citation(s) in RCA: 59] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 07/20/2018] [Accepted: 07/26/2018] [Indexed: 11/05/2022]
Abstract
Toxicological research of novel nanomaterials is a major developmental step of their clinical approval. Since iron oxide magnetic nanoparticles have a great potential in cancer treatment and diagnostics, the investigation of their toxic properties is very topical. In this paper we synthesized bovine serum albumin-coated iron oxide nanoparticles with different sizes and their polyethylene glycol derivative. To prove high biocompatibility of obtained nanoparticles the number of in vitro toxicological tests on human fibroblasts and U251 glioblastoma cells was performed. It was shown that albumin nanoparticles' coating provides a stable and biocompatible shell and prevents cytotoxicity of magnetite core. On long exposure times (48 hours), cytotoxicity of iron oxide nanoparticles takes place due to free radical production, but this toxic effect may be neutralized by using polyethylene glycol modification.
Collapse
Affiliation(s)
- Maxim A Abakumov
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation.,Laboratory of Biomedical Nanomaterials, National University of Science and Technology MISiS, Moscow, Russian Federation
| | - Alevtina S Semkina
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Alexander S Skorikov
- Electron Microscopy for Materials Science (EMAT), University of Antwerp, Antwerp, Belgium
| | - Daniil A Vishnevskiy
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Anna V Ivanova
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology MISiS, Moscow, Russian Federation
| | - Elena Mironova
- Laboratory of Cell and Tissue Growth, Federal State Institution of Science Institute of Theoretical and Experimental Biophysics, Russian Academy of Science, Pushchino, Russian Federation
| | - Galina A Davydova
- Laboratory of Cell and Tissue Growth, Federal State Institution of Science Institute of Theoretical and Experimental Biophysics, Russian Academy of Science, Pushchino, Russian Federation
| | - Alexander G Majouga
- Laboratory of Biomedical Nanomaterials, National University of Science and Technology MISiS, Moscow, Russian Federation.,University Administration, Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russian Federation
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| |
Collapse
|
39
|
Efremova MV, Naumenko VA, Spasova M, Garanina AS, Abakumov MA, Blokhina AD, Melnikov PA, Prelovskaya AO, Heidelmann M, Li ZA, Ma Z, Shchetinin IV, Golovin YI, Kireev II, Savchenko AG, Chekhonin VP, Klyachko NL, Farle M, Majouga AG, Wiedwald U. Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics. Sci Rep 2018; 8:11295. [PMID: 30050080 PMCID: PMC6062557 DOI: 10.1038/s41598-018-29618-w] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Accepted: 07/16/2018] [Indexed: 12/21/2022] Open
Abstract
High-quality, 25 nm octahedral-shaped Fe3O4 magnetite nanocrystals are epitaxially grown on 9 nm Au seed nanoparticles using a modified wet-chemical synthesis. These Fe3O4-Au Janus nanoparticles exhibit bulk-like magnetic properties. Due to their high magnetization and octahedral shape, the hybrids show superior in vitro and in vivo T2 relaxivity for magnetic resonance imaging as compared to other types of Fe3O4-Au hybrids and commercial contrast agents. The nanoparticles provide two functional surfaces for theranostic applications. For the first time, Fe3O4-Au hybrids are conjugated with two fluorescent dyes or the combination of drug and dye allowing the simultaneous tracking of the nanoparticle vehicle and the drug cargo in vitro and in vivo. The delivery to tumors and payload release are demonstrated in real time by intravital microscopy. Replacing the dyes by cell-specific molecules and drugs makes the Fe3O4-Au hybrids a unique all-in-one platform for theranostics.
Collapse
Affiliation(s)
- Maria V Efremova
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Victor A Naumenko
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Marina Spasova
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany
| | - Anastasiia S Garanina
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Maxim A Abakumov
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
- Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russian Federation
| | - Anastasia D Blokhina
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
| | - Pavel A Melnikov
- Department of Fundamental and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health and Social Development of the Russian Federation, Moscow, 119034, Russian Federation
| | | | - Markus Heidelmann
- ICAN - Interdisciplinary Center for Analytics on the Nanoscale and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany
| | - Zi-An Li
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany
| | - Zheng Ma
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany
| | - Igor V Shchetinin
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Yuri I Golovin
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
- Derzhavin Tambov State University, Nanocenter, Tambov, 392000, Russian Federation
| | - Igor I Kireev
- A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
| | - Alexander G Savchenko
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russian Federation
- Department of Fundamental and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health and Social Development of the Russian Federation, Moscow, 119034, Russian Federation
| | - Natalia L Klyachko
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation
| | - Michael Farle
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany
| | - Alexander G Majouga
- Department of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
- D. Mendeleev University of Chemical Technology of Russia, Moscow, 125047, Russian Federation.
| | - Ulf Wiedwald
- National University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
- Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
| |
Collapse
|
40
|
Stepanova OV, Voronova АD, Chadin AV, Valikhov MP, Abakumov MA, Reshetov IV, Chekhonin VP. Isolation of Rat Olfactory Ensheathing Cells and Their Use in the Therapy of Posttraumatic Cysts of the Spinal Cord. Bull Exp Biol Med 2018; 165:132-135. [PMID: 29796806 DOI: 10.1007/s10517-018-4114-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2017] [Indexed: 01/12/2023]
Abstract
We evaluated the efficacy of rat olfactory ensheathing cells in the therapy of experimental cysts of the spinal cord. Improvement of the motor function of the hind limbs after transplantation of the olfactory ensheathing cells into the posttraumatic spinal cord cysts rats was found. We also determined the required number of cells for transplantation and demonstrated a neuroprotective effect of this dosage. For further clinical studies, autologous tissue-specific cell preparation of olfactory ensheathing cells has to be created. Cell therapy in combination surgical and pharmacological treatment will substantially improve the quality of life of patients with posttraumatic spinal cord cysts.
Collapse
Affiliation(s)
- O V Stepanova
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Centre for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.
| | - А D Voronova
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Centre for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.,Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A V Chadin
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Centre for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M P Valikhov
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Centre for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M A Abakumov
- Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - I V Reshetov
- University Clinical Hospital No. 1, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Chekhonin
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Centre for Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.,Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
41
|
Semkina AS, Abakumov MA, Skorikov AS, Abakumova TO, Melnikov PA, Grinenko NF, Cherepanov SA, Vishnevskiy DA, Naumenko VA, Ionova KP, Majouga AG, Chekhonin VP. Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer. Nanomedicine 2018; 14:1733-1742. [PMID: 29730399 DOI: 10.1016/j.nano.2018.04.019] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2017] [Revised: 04/09/2018] [Accepted: 04/23/2018] [Indexed: 12/27/2022]
Abstract
In presented paper we have developed new system for cancer theranostics based on vascular endothelial growth factor (VEGF) targeted magnetic nanoparticles. Conjugation of anti-VEGF antibodies with bovine serum albumin coated PEGylated magnetic nanoparticles allows for improved binding with murine breast adenocarcinoma 4T1 cell line and facilitates doxorubicin delivery to tumor cells. It was shown that intravenous injection of doxorubicin loaded VEGF targeted nanoparticles increases median survival rate of mice bearing 4T1 tumors up to 50%. On the other hand magnetic resonance imaging (MRI) of 4T1 tumors 24 h after intravenous injection showed accumulation of nanoparticles in tumors, thus allowing simultaneous cancer therapy and diagnostics.
Collapse
Affiliation(s)
- Alevtina S Semkina
- Pirogov Russian National Research Medical University, Moscow, Russian Federation; The National University of Science and Technology MISiS, Moscow, Russian Federation
| | - Maxim A Abakumov
- Pirogov Russian National Research Medical University, Moscow, Russian Federation; The National University of Science and Technology MISiS, Moscow, Russian Federation.
| | | | | | - Pavel A Melnikov
- Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Nadejda F Grinenko
- Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Sergey A Cherepanov
- Pirogov Russian National Research Medical University, Moscow, Russian Federation; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Daniil A Vishnevskiy
- Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Victor A Naumenko
- The National University of Science and Technology MISiS, Moscow, Russian Federation
| | - Klavdiya P Ionova
- Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Alexander G Majouga
- The National University of Science and Technology MISiS, Moscow, Russian Federation; Lomonosov Moscow State University, Moscow, Russian Federation; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russian Federation
| | - Vladimir P Chekhonin
- Pirogov Russian National Research Medical University, Moscow, Russian Federation; Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| |
Collapse
|
42
|
Nikitin AA, Shchetinin IV, Tabachkova NY, Soldatov MA, Soldatov AV, Sviridenkova NV, Beloglazkina EK, Savchenko AG, Fedorova ND, Abakumov MA, Majouga AG. Synthesis of Iron Oxide Nanoclusters by Thermal Decomposition. Langmuir 2018; 34:4640-4650. [PMID: 29566327 DOI: 10.1021/acs.langmuir.8b00753] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
Herein, we report a novel one-step solvothermal synthesis of magnetite nanoclusters (MNCs). In this report, we discuss the synthesis, structure, and properties of MNCs and contrast enhancement in T2-weighted MR images using magnetite nanoclusters. The effect of different organic acids, used as surfactants, on the size and shape of MNCs was investigated. The structure and properties of samples were determined by magnetic measurements, TGA, TEM, HRTEM, XRD, FTIR, and MRI. Magnetic measurements show that obtained MNCs have relatively high saturation magnetization values (65.1-81.5 emu/g) and dependence of the coercive force on the average size of MNCs was established. MNCs were transferred into an aqueous medium by Pluronic F-127, and T2-relaxivity values were determined. T2-Weighted MR phantom images clearly demonstrated that such magnetite nanoclusters can be used as contrast agents for MRI.
Collapse
Affiliation(s)
- Aleksey A Nikitin
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
- Department of Chemistry , Lomonosov Moscow State University , Leninskiye gory 1-3, GSP-1 , 119991 Moscow , Russian Federation
| | - Igor V Shchetinin
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
| | - Natalya Yu Tabachkova
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
| | - Mikhail A Soldatov
- Southern Federal University , Bolshaya Sadovaya st., 105 , 344006 Rostov-on-Don , Russian Federation
| | - Alexander V Soldatov
- Southern Federal University , Bolshaya Sadovaya st., 105 , 344006 Rostov-on-Don , Russian Federation
| | - Natalya V Sviridenkova
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
| | - Elena K Beloglazkina
- Department of Chemistry , Lomonosov Moscow State University , Leninskiye gory 1-3, GSP-1 , 119991 Moscow , Russian Federation
| | - Alexander G Savchenko
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
| | - Natalya D Fedorova
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
| | - Maxim A Abakumov
- Department of Chemistry , Lomonosov Moscow State University , Leninskiye gory 1-3, GSP-1 , 119991 Moscow , Russian Federation
- The Russian National Research Medical University , Ostrovityanova 1 , 117997 Moscow , Russian Federation
| | - Alexander G Majouga
- National University of Science and Technology "MISIS" , Leninskiy prospect 4 , 119991 Moscow , Russian Federation
- Department of Chemistry , Lomonosov Moscow State University , Leninskiye gory 1-3, GSP-1 , 119991 Moscow , Russian Federation
- Dmitry Mendeleev University of Chemical Technology of Russia , Miusskaya 9 , 125047 Moscow , Russian Federation
| |
Collapse
|
43
|
Zhang C, Chen K, Han X, Fu J, Douglas P, Morozova AY, Abakumov MA, Gubsky IL, Li D, Guo J, Zhang X, Wang G, Chekhonin VP. Diffusion Tensor Imaging in Diagnosis of Post-Traumatic Syringomyelia in Spinal Cord Injury in Rats. Med Sci Monit 2018; 24:177-182. [PMID: 29311540 PMCID: PMC5771161 DOI: 10.12659/msm.907955] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Background Post-traumatic syringomyelia (PTS) is a common disease after spinal cord injury (SCI). The present study was performed to evaluate the advantages of diffusion tensor imaging (DTI) in estimating SCI and prognosing PTS in SCI rats. Material/Methods Forty rats were divided into 3 groups based on the extent of the individual SCI and PTS: a control group (n=10), a PTS group (n=8), and an SCI group (n=22). BBB tests were performed preoperatively and postoperatively at (1 d, 3 d, 5 d, 1 w, 2 w, 1 w, 2 w, 3 w, 4 w, 5 w, and 6 w). MRI T2 scanning was conducted postoperatively at (1 w, 2 w, 3 w, 4 w, 5 w, 6 w). DTI and diffusion tensor tractography were used for analyzing neuro-fiber changes after SCI. Results BBB scoring showed no differences between the PTS group and SCI group (P<0.05). PTS was found in 8 rats after SCI. MRI showed PTS formation in 3 rats at 2 w after SCI, and 5 rats showed PTS formation at postoperative 3w after SCI. Compared with the control group, ADC showed significant increase in both the PTS group (P<0.05) and the SCI group (P<0.05), FA showed significant decreases in the PTS (P<0.05) and SCI (P<0.05) groups. Compared with the SCI group, the PTS group showed an increase in ADC, but no statistical difference was found in ADC (P>0.05). The PTS group showed a significant increase in FA (P<0.05). Conclusions The combination of diffusion tensor imaging and diffusion tensor tractography has characteristics of high-sensitivity and quantitation for PTS prognosis. FA is predictive in the prognosis of PTS formation after SCI.
Collapse
Affiliation(s)
- Chao Zhang
- Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China (mainland).,Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Kai Chen
- Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin, China (mainland).,Department of Tumor Intervention, Tianjin 4th Centre Hospital, Tianjin, China (mainland)
| | - Xiuxin Han
- Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China (mainland)
| | | | | | - Anna Y Morozova
- Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Maxim A Abakumov
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Ilya L Gubsky
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Dejin Li
- Tianjin Key Laboratory for Prevention and Control of Occupational and Environmental Hazards, Logistics University of The People's Armed Police Force, Tianjin, China (mainland)
| | - Jin Guo
- Tianjin Key Laboratory for Prevention and Control of Occupational and Environmental Hazards, Logistics University of The People's Armed Police Force, Tianjin, China (mainland)
| | - Xuening Zhang
- Department of Tumor Intervention, Tianjin 4th Centre Hospital, Tianjin, China (mainland)
| | - Guowen Wang
- Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China (mainland)
| | - Vladimir P Chekhonin
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation.,Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| |
Collapse
|
44
|
Mironov AF, Grin MA, Pantushenko IV, Ostroverkhov PV, Ivanenkov YA, Filkov GI, Plotnikova EA, Karmakova TA, Starovoitova AV, Burmistrova NV, Yuzhakov VV, Romanko YS, Abakumov MA, Ignatova AA, Feofanov AV, Kaplan MA, Yakubovskaya RI, Tsigankov AA, Majouga AG. Synthesis and Investigation of Photophysical and Biological Properties of Novel S-Containing Bacteriopurpurinimides. J Med Chem 2017; 60:10220-10230. [PMID: 29202233 DOI: 10.1021/acs.jmedchem.7b00577] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Novel hybrid molecule containing 2-mercaptoethylamine was synthesized starting from O-propyloxime-N-propoxy bacteriopurpurinimide (dipropoxy-BPI), which was readily oxidized in oxygen atmosphere yielding the corresponding disulfide analogue (disulfide-BPI). Spectral, photophysical, photodynamic, and biological properties of compound were properly evaluated. Compounds bearing disulfide moiety can directly interact with glutathione (GSH), thereby reducing its intracellular concentration. Indeed, mice sarcoma S37 cell line was treated in vitro with disulfide-BPI, yielding a CC50 value of 0.05 ± 0.005 μM. A relatively high level of singlet oxygen was detected. It was demonstrated (by fluorescence) that the PS was rapidly accumulated in a cancer nest (S37) at a relatively high level after 2 h upon intravenous administration. After 24 h, no traces of the molecule were detected in the tumor mass. Moreover, high photodynamic efficiency was demonstrated at doses of 150-300 J/cm2 against two different in vivo tumor models, achieving 100% regression of cancer growth.
Collapse
Affiliation(s)
- Andrey F Mironov
- Moscow Technological University , 86 Vernadsky Avenue, Moscow 119571, Russia
| | - Mikhail A Grin
- Moscow Technological University , 86 Vernadsky Avenue, Moscow 119571, Russia
| | - Ivan V Pantushenko
- Moscow Technological University , 86 Vernadsky Avenue, Moscow 119571, Russia
| | - Petr V Ostroverkhov
- Moscow Technological University , 86 Vernadsky Avenue, Moscow 119571, Russia
| | - Yan A Ivanenkov
- Chemistry Department, Moscow State University , Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russia.,Institute of Biochemistry and Genetics Ufa Science Centre Russian Academy of Sciences (IBG RAS), Ufa, Bashkortostan, Russian Federation
| | - Gleb I Filkov
- Moscow Institute of Physics and Technology (MIPT) , 9 Institutskiy Per., Dolgoprudny, Moscow Region 141700, Russia
| | - Ekaterina A Plotnikova
- Branch, National Medical Radiology Research Center, P. A. Herzen Moscow Oncology Research Institute , 3 2nd Botkinskiy Proezd, Moscow 125284, Russia
| | - Tatyana A Karmakova
- Branch, National Medical Radiology Research Center, P. A. Herzen Moscow Oncology Research Institute , 3 2nd Botkinskiy Proezd, Moscow 125284, Russia
| | - Anna V Starovoitova
- A. Tsyb Medical Radiological Research Centre (A. Tsyb MRRC) , 10 Zhukov Street, Obninsk, Kaluga Region, 249031, Russia
| | - Nelli V Burmistrova
- A. Tsyb Medical Radiological Research Centre (A. Tsyb MRRC) , 10 Zhukov Street, Obninsk, Kaluga Region, 249031, Russia
| | - Vadim V Yuzhakov
- A. Tsyb Medical Radiological Research Centre (A. Tsyb MRRC) , 10 Zhukov Street, Obninsk, Kaluga Region, 249031, Russia
| | - Yuri S Romanko
- A. Tsyb Medical Radiological Research Centre (A. Tsyb MRRC) , 10 Zhukov Street, Obninsk, Kaluga Region, 249031, Russia
| | - Maxim A Abakumov
- Pirogov Russian National Research Medical University (RNRMU) , 1 Ostrovitianov Street, Moscow 117997, Russia.,National University of Science and Technology MISiS , Leninsky Prospect 4, Moscow 119049, Russia
| | - Anastasiya A Ignatova
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS , GSP-7, Ulitsa Miklukho-Maklaya 16/10, Moscow 117997, Russia.,Biology Faculty, Lomonosov Moscow State University , Leninskie Gory 1/70, Moscow 119992, Russia
| | - Alexey V Feofanov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS , GSP-7, Ulitsa Miklukho-Maklaya 16/10, Moscow 117997, Russia.,Biology Faculty, Lomonosov Moscow State University , Leninskie Gory 1/70, Moscow 119992, Russia
| | - Mikhail A Kaplan
- A. Tsyb Medical Radiological Research Centre (A. Tsyb MRRC) , 10 Zhukov Street, Obninsk, Kaluga Region, 249031, Russia
| | - Raisa I Yakubovskaya
- Branch, National Medical Radiology Research Center, P. A. Herzen Moscow Oncology Research Institute , 3 2nd Botkinskiy Proezd, Moscow 125284, Russia
| | - Anatoliy A Tsigankov
- Institute of Fundamental Problems of Biology, Russian Academy of Sciences Pushino, Moscow Region 142290, Russia
| | - Alexander G Majouga
- Chemistry Department, Moscow State University , Leninskie Gory, Building 1/3, GSP-1, Moscow 119991, Russia.,National University of Science and Technology MISiS , Leninsky Prospect 4, Moscow 119049, Russia
| |
Collapse
|
45
|
Baklaushev VP, Kilpeläinen A, Petkov S, Abakumov MA, Grinenko NF, Yusubalieva GM, Latanova AA, Gubskiy IL, Zabozlaev FG, Starodubova ES, Abakumova TO, Isaguliants MG, Chekhonin VP. Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer. Sci Rep 2017; 7:7715. [PMID: 28798322 PMCID: PMC5552689 DOI: 10.1038/s41598-017-07851-z] [Citation(s) in RCA: 77] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2016] [Accepted: 07/04/2017] [Indexed: 01/08/2023] Open
Abstract
Implantation of reporter-labeled tumor cells in an immunocompetent host involves a risk of their immune elimination. We have studied this effect in a mouse model of breast cancer after the orthotopic implantation of mammary gland adenocarcinoma 4T1 cells genetically labelled with luciferase (Luc). Mice were implanted with 4T1 cells and two derivative Luc-expressing clones 4T1luc2 and 4T1luc2D6 exhibiting equal in vitro growth rates. In vivo, the daughter 4T1luc2 clone exhibited nearly the same, and 4T1luc2D6, a lower growth rate than the parental cells. The metastatic potential of 4T1 variants was assessed by magnetic resonance, bioluminescent imaging, micro-computed tomography, and densitometry which detected 100-μm metastases in multiple organs and bones at the early stage of their development. After 3-4 weeks, 4T1 generated 11.4 ± 2.1, 4T1luc2D6, 4.5 ± 0.6; and 4T1luc2, <1 metastases per mouse, locations restricted to lungs and regional lymph nodes. Mice bearing Luc-expressing tumors developed IFN-γ response to the dominant CTL epitope of Luc. Induced by intradermal DNA-immunization, such response protected mice from the establishment of 4T1luc2-tumors. Our data show that natural or induced cellular response against the reporter restricts growth and metastatic activity of the reporter-labelled tumor cells. Such cells represent a powerful instrument for improving immunization technique for cancer vaccine applications.
Collapse
Affiliation(s)
- V P Baklaushev
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russia.
| | - A Kilpeläinen
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
| | - S Petkov
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
| | - M A Abakumov
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - N F Grinenko
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - G M Yusubalieva
- Department of Fundamental and Applied Neurobiology, Serbsky National Research Center for Social and Forensic Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia
| | - A A Latanova
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
- Chumakov Federal Scientific Center for Research and Development of Immunobiological Preparations, Moscow, Russia
| | - I L Gubskiy
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - F G Zabozlaev
- Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russia
| | - E S Starodubova
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
- Chumakov Federal Scientific Center for Research and Development of Immunobiological Preparations, Moscow, Russia
| | - T O Abakumova
- Department of Fundamental and Applied Neurobiology, Serbsky National Research Center for Social and Forensic Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia
| | - M G Isaguliants
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- Chumakov Federal Scientific Center for Research and Development of Immunobiological Preparations, Moscow, Russia.
- N.F. Gamaleya Research Center of Epidemiology and Microbiology, Moscow, Russia.
- Riga Stradins University, Riga, Latvia.
| | - V P Chekhonin
- Research and Education Center for Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
- Department of Fundamental and Applied Neurobiology, Serbsky National Research Center for Social and Forensic Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
46
|
Semkina AS, Abakumov MA, Abakumov AM, Nukolova NV, Chekhonin VP. Relationship between the Size of Magnetic Nanoparticles and Efficiency of MRT Imaging of Cerebral Glioma in Rats. Bull Exp Biol Med 2016; 161:292-5. [PMID: 27383161 DOI: 10.1007/s10517-016-3398-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Indexed: 10/21/2022]
Abstract
BSA-coated Fe3O4 nanoparticles with different hydrodynamic diameters (36±4 and 85±10 nm) were synthesized, zeta potential and T2 relaxivity were determined, and their morphology was studied by transmission electron microscopy. Studies on rats with experimental glioma C6 showed that smaller nanoparticles more effectively accumulated in the tumor and circulated longer in brain vessels. Optimization of the hydrodynamic diameter improves the efficiency of MRT contrast agent.
Collapse
Affiliation(s)
- A S Semkina
- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia.
| | - M A Abakumov
- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia
| | - A M Abakumov
- Electron Microscopy for Materials Science (EMAT), University of Antwerp, Groenenborgerlaan, Antwerp, Belgium
| | - N V Nukolova
- V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Chekhonin
- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Moscow, Russia
- V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
47
|
Zhang C, Morozova AY, Abakumov MA, Gubsky IL, Douglas P, Feng S, Bryukhovetskiy AS, Chekhonin VP. Precise Delivery Into Chronic Spinal Cord Injury Syringomyelic Cysts with Magnetic Nanoparticles MRI Visualization. Med Sci Monit 2015; 21:3179-85. [PMID: 26486048 PMCID: PMC4621156 DOI: 10.12659/msm.895624] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Accepted: 10/02/2015] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND Traumatic spinal cord injury (SCI) often results in the deficiency of glia and neurons in cystic cavities. These syringomyelic cysts can prevent axonal regeneration and sprouting. Details of the mechanism of syringomyelic cyst formation are unknown and an effective treatment for overcoming syringomyelic cysts is not available. MATERIAL AND METHODS Ten adult female Wistar rats underwent contusion SCI modeling resulting in syringomyelic cyst formation. A novel method for locating the cysts was developed and employed. MRI safe silver needles were inserted through the erector spinae of anesthetized rats to create a stable reference point. MRI images of the rodent spine were taken with the needles in situ. This information was used to accurately locate the cyst and determine the 3-dimensional entry point coordinates for nanoparticle delivery. Nanoparticles were injected into the cyst during a primary injection of 8 ul and a secondary injection of 8 ul, to prove the procedure can be accurately repeated. RESULTS None of the rats died intra- or post-operatively. The syringomyelic cysts were accurately located with the 3-dimensional entry point coordinates. After nanoparticle delivery twice into each rat, the visualized syringomyelic cyst volume significantly decreased from 5.71±0.21 mm3 to 3.23±0.364 mm3 and to 1.48±0.722 mm3. CONCLUSIONS The present study describes a novel strategy for precise nanoparticle delivery into a syringomyelic cyst, using measurements obtained from MRI images. This strategy may aid in developing a new method for studying chronic spinal cord injury and a novel treatment for syringomyelic cysts.
Collapse
Affiliation(s)
- Chao Zhang
- Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, P.R. China
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
- Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Anna Y. Morozova
- Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| | - Maxim A. Abakumov
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Ilya L. Gubsky
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
| | - Patricia Douglas
- Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, P.R. China
| | - Shiqing Feng
- Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin, P.R. China
| | - Andrey S. Bryukhovetskiy
- Center for Biomedical Technologies, Federal Research and Clinical Center for Specialized Types of Medical Assistance and Medical Technologies of The Federal Medical Biological Agency, Moscow, Russian Federation
| | - Vladimir P. Chekhonin
- Department of Medicinal Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russian Federation
- Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation
| |
Collapse
|
48
|
Baklaushev VP, Grinenko NF, Yusubalieva GM, Abakumov MA, Gubskii IL, Cherepanov SA, Kashparov IA, Burenkov MS, Rabinovich EZ, Ivanova NV, Antonova OM, Chekhonin VP. Modeling and integral X-ray, optical, and MRI visualization of multiorgan metastases of orthotopic 4T1 breast carcinoma in BALB/c mice. Bull Exp Biol Med 2015; 158:581-8. [PMID: 25705045 DOI: 10.1007/s10517-015-2810-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2014] [Indexed: 10/24/2022]
Abstract
A model of highly metastasizing orthotopic allogeneic breast carcinoma was reproduced and standardized in experiments on BALB/c mice. 4T1 cells characterized by high metastatic activity were transfected with red fluorescent protein (RFP) gene or firefly luciferase (Luc2) gene. Unmodified 4T1 cells and modified 4T1-RFP and 4T1-Luc2 cells were subcutaneously injected to mature female mice into the second mammary fat pads. Quantitative evaluation of the primary node and visceral metastases was performed using magnetic-resonance imaging, X-ray and optical tomography. Modification of 4T1 cells with RFP gene considerably reduced their invasive and metastatic potential and led to spontaneous regression of the primary tumor in 20% cases. Modification of 4T1 cells with Luc2 gene had practically no effect on proliferative, invasive, and metastatic characteristics of the tumor and provided the possibility of quantitative analysis of the primary tumor dynamics by the luminescence intensity. The survival median in mice receiving unmodified 4T1 cells and transfected 4T1-RFP and 4Т1-Luc2 cells was 32, 42, and 38 days, respectively. Neither primary node nor tumor metastases accumulated gadolinium-containing contrast agent and Alasens fluorescent tracer. After implantation of 4T1 and 4Т1-Luc2 cells, multiple metastases were more often detected in the lungs, liver, spleen, spine, and regional lymph nodes and less frequently in the brain, which corresponded to metastasizing profile of human breast cancer. The developed model of orthotopic breast carcinoma 4T1 in BALB/c mice with complex detection of multiple organ metastases using X-ray microCT, optical, and MRI can be recommended for preclinical studies of new antitumor preparations.
Collapse
Affiliation(s)
- V P Baklaushev
- Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia,
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Abakumov MA, Nukolova NV, Sokolsky-Papkov M, Shein SA, Sandalova TO, Vishwasrao HM, Grinenko NF, Gubsky IL, Abakumov AM, Kabanov AV, Chekhonin VP. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor. Nanomedicine 2015; 11:825-33. [PMID: 25652902 DOI: 10.1016/j.nano.2014.12.011] [Citation(s) in RCA: 82] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Revised: 12/02/2014] [Accepted: 12/13/2014] [Indexed: 11/15/2022]
Abstract
UNLABELLED This work is focused on synthesis and characterization of targeted magnetic nanoparticles as magnetic resonance imaging (МRI) agents for in vivo visualization of gliomas. Ferric oxide (Fe3O4) cores were synthesized by thermal decomposition and coated with bovine serum albumin (BSA) to form nanoparticles with Deff of 53±9nm. The BSA was further cross-linked to improve colloidal stability. Monoclonal antibodies against vascular endothelial growth factor (mAbVEGF) were covalently conjugated to BSA through a polyethyleneglycol linker. Here we demonstrate that 1) BSA coated nanoparticles are stable and non-toxic to different cells at concentration up to 2.5mg/mL; 2) conjugation of monoclonal antibodies to nanoparticles promotes their binding to VEGF-positive glioma С6 cells in vitro; 3) targeted nanoparticles are effective in MRI visualization of the intracranial glioma. Thus, mAbVEGF-targeted BSA-coated magnetic nanoparticles are promising MRI contrast agents for glioma visualization. FROM THE CLINICAL EDITOR This work focuses on synthesis and characterization of targeted magnetic nanoparticles as magnetic resonance imaging (МRI) agents for in vivo visualization of gliomas. The authors utilize the fact that high-grade gliomas have extensive areas of necrosis and hypoxia, which results in increased secretion of angiogenesis vascular endothelial growth factor (VEGF). Monoclonal antibodies against vascular endothelial growth factor (mAbVEGF) were covalently conjugated to crosslinked BSA coated ferric oxide (Fe3O4) nanoparticles. The results show that these targeted nanoparticles are effective in MRI visualization of the intracranial glioma and may provide a new and promising contrast agent.
Collapse
Affiliation(s)
- Maxim A Abakumov
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia; Laboratory of Chemical Design of Bionanomaterials, Chemistry Department, M.V. Lomonosov Moscow State University, Moscow, Russia.
| | - Natalia V Nukolova
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia; Division of Fundamental and Applied Neurobiology, Serbsky State Research Center of Social and Forensic Psychiatry, Moscow, Russia; Laboratory of Chemical Design of Bionanomaterials, Chemistry Department, M.V. Lomonosov Moscow State University, Moscow, Russia
| | - Marina Sokolsky-Papkov
- Center for Nanotechnology in Drug Delivery and Division of Molecular Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Sergey A Shein
- Division of Fundamental and Applied Neurobiology, Serbsky State Research Center of Social and Forensic Psychiatry, Moscow, Russia
| | - Tatiana O Sandalova
- Division of Fundamental and Applied Neurobiology, Serbsky State Research Center of Social and Forensic Psychiatry, Moscow, Russia
| | - Hemant M Vishwasrao
- Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA; Center for Nanotechnology in Drug Delivery and Division of Molecular Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Nadezhda F Grinenko
- Center for Nanotechnology in Drug Delivery and Division of Molecular Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Iliya L Gubsky
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Artem M Abakumov
- Electron Microscopy for Materials Science (EMAT), University of Antwerp, Groenenborgerlaan 171, Belgium
| | - Alexander V Kabanov
- Laboratory of Chemical Design of Bionanomaterials, Chemistry Department, M.V. Lomonosov Moscow State University, Moscow, Russia; Center for Nanotechnology in Drug Delivery and Division of Molecular Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Vladimir P Chekhonin
- Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Moscow, Russia; Division of Fundamental and Applied Neurobiology, Serbsky State Research Center of Social and Forensic Psychiatry, Moscow, Russia
| |
Collapse
|
50
|
Nukolova NV, Baklaushev VP, Abakumova TO, Mel'nikov PA, Abakumov MA, Yusubalieva GM, Bychkov DA, Kabanov AV, Chekhonin VP. Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6. Bull Exp Biol Med 2014; 157:524-9. [PMID: 25110098 DOI: 10.1007/s10517-014-2606-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Indexed: 02/04/2023]
Abstract
The aim of this study was to create a nanocontainer conjugated with monoclonal antibodies to connexin 43 (Cx43) that is actively expressed at the periphery of C6 glioma and in the astroglia roll zone. Stable vector nanogels with high (up to 35%) cisplatin load were synthesized. The antitumor effects of Cx43-modified cisplatin-loaded nanogels, free cisplatin, and nonspecific drugs were carried out on C6 glioma model. Vector nanogels reduced systemic toxicity of cisplatin, effectively inhibited tumor growth, and significantly prolonged the lifespan of animals with experimental tumors.
Collapse
Affiliation(s)
- N V Nukolova
- Department of Medical Nanobiotechnologies, Biomedical Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia,
| | | | | | | | | | | | | | | | | |
Collapse
|